Dark | Light
# ![@bullishbruk Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::44545258.png) @bullishbruk Bullish

Bullish posts on X about $ibrx, dr, for all, in the the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::44545258/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::44545258/c:line/m:interactions.svg)

- [--] Week [-------] +173%
- [--] Month [-------] +160%
- [--] Months [---------] +474%
- [--] Year [---------] +12,865%

### Mentions: [--] [#](/creator/twitter::44545258/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::44545258/c:line/m:posts_active.svg)

- [--] Week [--] +15%
- [--] Month [---] +45%
- [--] Months [---] +386%
- [--] Year [-----] +763%

### Followers: [-----] [#](/creator/twitter::44545258/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::44545258/c:line/m:followers.svg)

- [--] Week [-----] +0.99%
- [--] Month [-----] +14%
- [--] Months [-----] +45%
- [--] Year [-----] +61%

### CreatorRank: [-------] [#](/creator/twitter::44545258/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::44545258/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  97.81% [stocks](/list/stocks)  8.76% [countries](/list/countries)  5.11% [celebrities](/list/celebrities)  4.38% [technology brands](/list/technology-brands)  2.19% [exchanges](/list/exchanges)  1.46% [social networks](/list/social-networks)  0.73%

**Social topic influence**
[$ibrx](/topic/$ibrx) #8, [dr](/topic/dr) 10.22%, [for all](/topic/for-all) 6.57%, [in the](/topic/in-the) 5.84%, [bullish](/topic/bullish) #167, [alc](/topic/alc) 4.38%, [just a](/topic/just-a) 4.38%, [end of](/topic/end-of) 4.38%, [matter](/topic/matter) 4.38%, [elon musk](/topic/elon-musk) 3.65%

**Top accounts mentioned or mentioned by**
[@drpatrick](/creator/undefined) [@drmakaryfda](/creator/undefined) [@immunitybio](/creator/undefined) [@lorimills4ca42](/creator/undefined) [@alc2022](/creator/undefined) [@seckennedy](/creator/undefined) [@nihdirectorjay](/creator/undefined) [@umbisam](/creator/undefined) [@usfda](/creator/undefined) [@vprasadmdmph](/creator/undefined) [@fda](/creator/undefined) [@truedat999](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@alhmd120690](/creator/undefined) [@potus](/creator/undefined) [@newstart2024](/creator/undefined) [@realdonaldtrump](/creator/undefined) [@drkashsarabi](/creator/undefined) [@megynkelly](/creator/undefined) [@tuckercarlson](/creator/undefined)

**Top assets mentioned**
[ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Candel Therapeutics, Inc. (CADL)](/topic/$cadl) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Duolingo, Inc.  (DUOL)](/topic/$duol) [Ambrx Biopharma, Inc.  (AMAM)](/topic/$amam)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Benzinga 01/16/2026 11:04 $IBRX +35.70% Hedge funds don't need headlines to move they need inflection points. ImmunityBio Inc(NASDAQ:IBRX) just delivered one. ImmunityBio stock has gone vertical up nearly 96% year-to-date but the real story isn't the stock move. It's the number behind it. On Thursday ImmunityBio reported $113 million in [----] revenue marking a staggering 700% year-over-year increase the kind of acceleration that turns early positioning into visible validation. The Revenue Inflection Hedge Funds Were Positioned For The most important data point wasn't just the full-year figure."  
[X Link](https://x.com/bullishbruk/status/2012225559212806149)  2026-01-16T18:08Z [----] followers, [----] engagements


"So far so good BIOTECH I am in $CADL $IBRX $IOVA and $SLS.for now out on $ATOS and $CAPR"  
[X Link](https://x.com/bullishbruk/status/2013737600012419462)  2026-01-20T22:17Z [----] followers, [----] engagements


"Youre right the ResQ201A phase [--] trial is actively recruiting and it randomizes post-ICI progressed advanced/metastatic NSCLC patients (ECOG 0-2) to: Experimental: N-803 + (PD-1) + docetaxel Control: docetaxel monotherapy Primary endpoint: OS. Docetaxel anchors both arms as the standard second-line backbone confirming chemos role for debulking and synergy post-ICI resistance. In PD-L1-low/negative NSCLC RWE/trials show chemo + PD-1 combos often outperform IO alone (higher ORR/PFS/OS). For terminal/advanced cancer patients (short horizons): RWE is key for accelerated approvals/expansions in"  
[X Link](https://x.com/bullishbruk/status/2018028209934082130)  2026-02-01T18:26Z [----] followers, [---] engagements


"I believe Elon Musk with his groundbreaking advancements in technology and Dr. Patrick Soon-Shiong through his pioneering work in biology immunotherapy and cancer treatments like ANKTIVA and next-generation immune activation therapies will stand as two of the most consequential figures of our time. $IBRX https://twitter.com/i/web/status/2019397046814257177 https://twitter.com/i/web/status/2019397046814257177"  
[X Link](https://x.com/bullishbruk/status/2019397046814257177)  2026-02-05T13:05Z [----] followers, [----] engagements


"What truly sets Dr. Patrick Soon-Shiong and Elon Musk apart is their shared unwavering focus on advancing humanity whether through revolutionary immunotherapy and cancer breakthroughs like ANKTIVA or through transformative technologies in space AI neural interfaces and sustainable energy rather than being primarily driven by profit. That rare priority on genuine progress over pure financial gain is what makes both of them so remarkable and inspiring. https://twitter.com/i/web/status/2019412114402628078 https://twitter.com/i/web/status/2019412114402628078"  
[X Link](https://x.com/bullishbruk/status/2019412114402628078)  2026-02-05T14:05Z [----] followers, [---] engagements


"Well respectfully I disagree. Elons drive might look self-focused but its about scaling solutions for humanity much like Dr. Soon-Shiongs. Theyve got mutual respect public props and joint forums. Give it time; collaborations between titans like them could still happen especially with aligned goals in AI-biotech crossovers or global health. $IBRX https://twitter.com/i/web/status/2019418938111635602 https://twitter.com/i/web/status/2019418938111635602"  
[X Link](https://x.com/bullishbruk/status/2019418938111635602)  2026-02-05T14:32Z [----] followers, [--] engagements


"$IBRX Cup with handle https://t.co/PZWUBoHKbM Cup with handle https://t.co/PZWUBoHKbM"  
[X Link](https://x.com/bullishbruk/status/2019430744909881434)  2026-02-05T15:19Z [----] followers, [----] engagements


"$IBRX ANKTIVA: The pioneering and only FDA-authorized therapy specifically targeting lymphopenia reversal in cancer patientsnow demonstrating dramatic immune restoration (reversing severe lymphopenia with significant ALC increases) and extended survival across multiple solid tumor types including chemo-free combos in recurrent glioblastoma where median OS is not yet reached. The science is stacking uplymphopenia reversal isnt just a side benefit; its increasingly tied to better survival across tumor types. When the data continues to validate this the price of $IBRX will catch up big time."  
[X Link](https://x.com/bullishbruk/status/2019521155032347121)  2026-02-05T21:18Z [----] followers, [----] engagements


"$IBRX My own 2cents ANKTIVA doesnt rely on political backingits a legitimate breakthrough for reversing lymphopenia (low NK/T-cell counts that cripple immunity in cancer patients). As a U.S. citizen I welcome any positive nods (including from leaders) but its value is universal: restoring immune competence benefits everyone everywhere. The real barrier is Big Pharma defending their turf but thats fading. With strong data mountingFDA Expanded Access for lymphopenia in solid tumors Saudi approvals for NSCLC and bladder cancer (world-firsts for subcutaneous IL-15 in some indications) ongoing"  
[X Link](https://x.com/bullishbruk/status/2019837936359940604)  2026-02-06T18:17Z [----] followers, [----] engagements


"$IBRX led by Dr. Patrick Soon-Shiong pioneers Immunotherapy 2.0activating NK/T/memory cells to reverse lymphopenia defeat cancer/infections and advance longevity. Consequential and BigPharma in the making. ANKTIVA: Chemo-free durable responses. Early approvals: US/UK/EU & Saudi FDA NMIBC CIS papillary + SC metastatic NSCLC w/CPI (world-first beyond bladder). Momentum: [----] rev $113M (700% YoY growth); strong quarterly surge. Data: High 3-yr survival cystectomy avoidance long remissions. Pipeline: ResQ215B P2 launched: Chemo/lympho-free CAR-NK + ANKTIVA + ritux in indolent NHL (Waldenstrms)."  
[X Link](https://x.com/bullishbruk/status/2020263733600350482)  2026-02-07T22:29Z [----] followers, [----] engagements


"$IBRX @VPrasadMDMPH @DrMakaryFDA Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): Its fully approved in the US for one rare form of bladder cancer but not for the common form most patients have. So even though the same drug is already FDA-approved and https://t.co/jb46zpPbPL Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): Its fully approved in the US for one rare form of bladder cancer but not for the common form most patients have. So even though the same drug is already"  
[X Link](https://x.com/bullishbruk/status/2022002612120494421)  2026-02-12T17:39Z [----] followers, [----] engagements


"Dear Senator Johnson I urge you to investigate the FDAs glaring double standard in oncology approvals. In June [----] the FDA granted Mercks Keytruda a broad tissue-agnostic approval for MSI-high tumors by pooling data from five single-arm trials. Some tumor types had only N=1 or N=2 patients different doses were used and the entire approval rested on this combined dataset (see Tables [--] and [--] page [--] of the June [----] package insert). Big Pharma received accelerated approval on the weakest possible evidence. Yet innovative biotechs developing next-generation immunotherapies including IL-15"  
[X Link](https://x.com/bullishbruk/status/2022021986621247841)  2026-02-12T18:56Z [----] followers, [----] engagements


"@I_Am_MikeJones I felt the same way on my recent $AMAM investment had 95K @$4.2sh averaging and when it jump to $6 waited to come down and it didnt and every time it goes up I say lets wait to by the dip but dip never came and one morning I wake up and been sold with a $28 price tag"  
[X Link](https://x.com/bullishbruk/status/1942949448079864197)  2025-07-09T14:10Z [----] followers, [---] engagements


"Here are my top SC biotech stocks $CADL $IBRX $IOVA these three among others may be a life changing opportunity $CAPR that was huge bank Not a financial advice please do your own DD"  
[X Link](https://x.com/bullishbruk/status/1998036021179720090)  2025-12-08T14:24Z [----] followers, [----] engagements


"$IBRX #ANKTIVA Oncology & Immunotherapy Market Context The global oncology market is massive and growing rapidly estimates range from $250$285B in [----] projected to reach $500$670B+ by [--------] (CAGR 911.5%). The cancer immunotherapy segment (where ANKTIVA fits) is even hotter: $226$260B in [--------] forecasted to hit $443$467B by [----] (CAGR 12%). PD-1/PD-L1 inhibitors (like Keytruda) dominate with the segment at $54$62B in [----] potentially doubling to $120$138B by [----]. IMO A $200B addressable market for ANKTIVA (standalone or combo) aligns with capturing a significant slice of the exploding"  
[X Link](https://x.com/bullishbruk/status/2012336698852618680)  2026-01-17T01:30Z [----] followers, 10.7K engagements


"$IBRX I have to thank Adam twice first $CAPR $6 to $30 and since he posted a hit job on $IBRX now it is up 6% on a red day. @adamfeuerstein keep it coming my brother. Thank you"  
[X Link](https://x.com/bullishbruk/status/2017309753236504862)  2026-01-30T18:51Z [----] followers, [----] engagements


"$IBRX The gold standard of randomized controlled trials (RCTs) has always faced scrutinyits not flawless. Look at history: Vioxx sailed through RCTs got FDA approval in [----] then got yanked in [----] after real-world data exposed massive heart attack/stroke risks killing thousands. Belviq passed trials for weight loss approved 2012pulled in [----] when post-approval evidence revealed cancer links. Meridia cleared RCTs approved 1997withdrawn [----] after real-world signals showed elevated heart attacks/strokes. These arent outliers; theyre proof. Nothings perfect. Thats why we need real-world"  
[X Link](https://x.com/bullishbruk/status/2018021402541003065)  2026-02-01T17:59Z [----] followers, [----] engagements


"@Humanspective We are going to need ANKTIVA $IBRX"  
[X Link](https://x.com/bullishbruk/status/2018901848099594289)  2026-02-04T04:18Z [----] followers, [----] engagements


"How much is a cancer cure #ANKTIVA $IBRX worths to you Were you aware that a cancer cure has existed for over a decade and just approved for lung cancer in Saudi Arabia. however that same drug is highly restricted in the United States Dr. Patrick Soon-Shiong went on air with Chris Cuomo and dropped a claim that shouldve https://t.co/mLdYPSREpe Were you aware that a cancer cure has existed for over a decade and just approved for lung cancer in Saudi Arabia. however that same drug is highly restricted in the United States Dr. Patrick Soon-Shiong went on air with Chris Cuomo and dropped a claim"  
[X Link](https://x.com/bullishbruk/status/2018904142182322262)  2026-02-04T04:27Z [----] followers, [----] engagements


"$IBRX is it time yet ANKTIVA is a national treasure @LoriMills4CA42 $IBRX OH HE WITH THE BIG HITTERS THIS IS GETTING GOOD https://t.co/AKZZmauEZy $IBRX OH HE WITH THE BIG HITTERS THIS IS GETTING GOOD https://t.co/AKZZmauEZy"  
[X Link](https://x.com/bullishbruk/status/2018985894234218570)  2026-02-04T09:52Z [----] followers, [----] engagements


"$IBRX ANKTIVAs trillion-dollar potential ties directly into Dr. Patrick Soon-Shiongs bold vision: supercharging the immune systemspecifically by activating and proliferating natural killer (NK) cells T cells and memory T cellscould unlock massive $ value in longevity cancer treatment and beyond. #MAHA finally gets it https://twitter.com/i/web/status/2019527359242838078 https://twitter.com/i/web/status/2019527359242838078"  
[X Link](https://x.com/bullishbruk/status/2019527359242838078)  2026-02-05T21:43Z [----] followers, [----] engagements


"$IBRX demonstrated impressive relative strength during yesterdays broader market sell-off holding far better than many peers in biotech and beyond. This resilience highlights growing investor confidence in its explosive growth story (ANKTIVA ramp pipeline catalysts) while positioning it as a smart hedge against bearish macro pressuresmore buyers are likely stepping in on these dips. @DavidDin @Umbisam https://twitter.com/i/web/status/2019711556146118935 https://twitter.com/i/web/status/2019711556146118935"  
[X Link](https://x.com/bullishbruk/status/2019711556146118935)  2026-02-06T09:55Z [----] followers, [----] engagements


"$IBRX agree wholeheartedly $IBRX actually holding up pretty well while other popular names are getting hammered is a sign of whats to come in my opinion. Essentially we have just trapped more shorts over the last few weeks. And if we continue to hold this relative strength compared to the other popular $IBRX actually holding up pretty well while other popular names are getting hammered is a sign of whats to come in my opinion. Essentially we have just trapped more shorts over the last few weeks. And if we continue to hold this relative strength compared to the other popular"  
[X Link](https://x.com/bullishbruk/status/2019712843478867999)  2026-02-06T10:00Z [----] followers, [----] engagements


"$IBRX πŸš€ ANKTIVA turns Saudi Arabia into CANCER MECCA #1 SFDA accelerated approvals Jan 26: WORLD-FIRST for metastatic NSCLC (w/ checkpoint inhibitors) + BCG-unresponsive bladder CIS ( papillary) πŸ’₯ Elite med tourists flock to Riyadhs King Faisal HospNK/T-cell revival reverses lymphopenia adds YEARS to life vs. FDAs Big Pharma stall πŸ˜‚ Dr. Pat + His Excellency Bandar al-Knawys BioShield Summit: ALL tumors next While US patients are waiting. @DrMakaryFDA APPROVE LYMPOPENIA NOW Wealthy flock in stock MOONSHOTshorts lose #MAHA @DrPatrick @SenRonJohnson @bullishbruk I am from Saudi Arabia and Ive"  
[X Link](https://x.com/bullishbruk/status/2019799810237256053)  2026-02-06T15:46Z [----] followers, [----] engagements


"When #LadyAnktiva speaks we listen $IBRX Unleash ANKTIVA NATIONWIDE for ALL cancer Patients. No More patient by patient approvals. Cancer Patients do not have time to wait. Every oncologist should be able to give Patients to option of choice #ANKTIVA @bullishbruk Unleash ANKTIVA NATIONWIDE for ALL cancer Patients. No More patient by patient approvals. Cancer Patients do not have time to wait. Every oncologist should be able to give Patients to option of choice #ANKTIVA @bullishbruk"  
[X Link](https://x.com/bullishbruk/status/2019892344078893408)  2026-02-06T21:53Z [----] followers, [----] engagements


"Spot on Mohammed. Meeting Dr. Soon-Shiong and seeing Saudis real commitment sealed itlong-term transformative bets like ANKTIVAs SFDA approvals. Hes a humble visionary focused on saving lives. $IBRX isnt just a stock; its the mission to protect our loved ones. I too have a conviction. Long-term. In this together. Thank you @DrPatrick I met Dr. Patrick Soon-Shiong (@DrPatrick) in Saudi Arabia and spoke with him personally. After the conference I invested heavily in $IBRX not as a trade but as conviction. My decision was driven by two core reasons: Saudi Arabias involvement because when Saudi I"  
[X Link](https://x.com/bullishbruk/status/2020273159031628150)  2026-02-07T23:07Z [----] followers, [----] engagements


"Immunity has been the core focus all along. We havent even scratched the surface of what ANKTIVA can truly achieve. I firmly believe it has the potential to become one of the blockbuster drugs of our generation. $IBRX @Umbisam $IBRX A quick google search will confirm my thoughts about the potential benefit of Anktiva in Alzheimers disease. There is an association between low ALC and Disease. When IBRX is cash positive maybe they would consider a trial. Expensive it will be. $IBRX A quick google search will confirm my thoughts about the potential benefit of Anktiva in Alzheimers disease. There"  
[X Link](https://x.com/bullishbruk/status/2020310839593783416)  2026-02-08T01:36Z [----] followers, [----] engagements


"Hands down @grok is one of the most intelligent of all. $IBRX @MartinezAyren @bigdickee Imagine the stock market is like a big playground where people buy and sell shares of companies like trading toys. $IBRX is a company that makes medicine. Normally trading happens during "playtime" (market hours). But after closing or before opening some big kids trade in a @MartinezAyren @bigdickee Imagine the stock market is like a big playground where people buy and sell shares of companies like trading toys. $IBRX is a company that makes medicine. Normally trading happens during "playtime" (market"  
[X Link](https://x.com/bullishbruk/status/2020328104615698502)  2026-02-08T02:45Z [----] followers, [----] engagements


"$IBRX ANKTIVA @DrPatrick hmmmm maybe there is a connection I am just asking for a friend 🚨 BREAKING South African AIDS Vaccine Begins Human Trials. https://t.co/zRqBvZ8Og3 🚨 BREAKING South African AIDS Vaccine Begins Human Trials. https://t.co/zRqBvZ8Og3"  
[X Link](https://x.com/bullishbruk/status/2020595994254336053)  2026-02-08T20:30Z [----] followers, [----] engagements


"Not so evil BigPharma in the making @PhoenxLights we appreciate it $IBRX @LoriMills4CA42 Immunitybio's HR recruiting video Amazing History and the end of cancer and infectious diseases is happening now Watch and share with all @DrPatrick @ImmunityBio https://t.co/K1qsOYnbdE Immunitybio's HR recruiting video Amazing History and the end of cancer and infectious diseases is happening now Watch and share with all @DrPatrick @ImmunityBio https://t.co/K1qsOYnbdE"  
[X Link](https://x.com/bullishbruk/status/2020860038202486882)  2026-02-09T13:59Z [----] followers, [----] engagements


"$IBRX Riyadh 2026: Igniting Immunotherapy [---] Anktiva + NK Cell Power for Breast Lung Prostate GBM & Beyond @DrMakaryFDA The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership in Saudi and setting the launch of Anktiva with NKcell therapy- immunotherapy [---] The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership"  
[X Link](https://x.com/bullishbruk/status/2020902539516920116)  2026-02-09T16:48Z [----] followers, [----] engagements


"$IBRX I agree wholeheartedly @DrPatrick $IBRX lets not lose sight that the leader of this project has the tenacity of a Michael Jordan the brains of a Jonas Salk and the salesmanship of a Steve Jobs. Bet on the man $IBRX lets not lose sight that the leader of this project has the tenacity of a Michael Jordan the brains of a Jonas Salk and the salesmanship of a Steve Jobs. Bet on the man"  
[X Link](https://x.com/bullishbruk/status/2021055880939307482)  2026-02-10T02:57Z [----] followers, [----] engagements


"$IBRX you think so How about heading to all time high $46 @Umbisam @alc2022 $IBRX may be headed back to recent highs. https://t.co/caDij17N8H $IBRX may be headed back to recent highs. https://t.co/caDij17N8H"  
[X Link](https://x.com/bullishbruk/status/2021056515797549098)  2026-02-10T02:59Z [----] followers, [----] engagements


"$IBRX crew has anyone else noticed Every time @adamfeuerstein drops his latest hit piece on IBRX the stock pumps like clockwork. Coincidence Nah. The mans basically our secret bullish catalyst at this point. Keep the shade coming Adam youre doing the Lords work (for the longs). @Umbisam @alc2022 @Alhmd120690 https://twitter.com/i/web/status/2021219542148497667 https://twitter.com/i/web/status/2021219542148497667"  
[X Link](https://x.com/bullishbruk/status/2021219542148497667)  2026-02-10T13:47Z [----] followers, [----] engagements


"$IBRX do you believe RFK and @DrMakaryFDA are trying to sanitize the FDA IMO: The FDA isnt a health agency and never has beenits a captured corrupt institution run by Big Pharma loyalists. After the scamdemic disaster zero real prosecutions of the worst offenders proves the rot goes all the way to the top. The agency has zero remaining credibility; an FDA stamp now means suspicion not safety for millions. Until the most blatant criminals are publicly prosecuted and removed trust cannot return. The worst long-term positions must be gutted and replaced with truly independent unowned people."  
[X Link](https://x.com/bullishbruk/status/2021224896571842757)  2026-02-10T14:09Z [----] followers, [----] engagements


"Hell yeah @Alhmd120690 prophecy or conviction Either way youre the man $IBRX to $15+ by Feb end Ballsy call. Games in Riyadh not Wall Street: SFDA approvals for ANKTIVA in all cancer types coming regional office plans MENA momentum. Wall Streets catching up slow but Saudi ties = big unlock. Some remember others regret. Reposted saved riding. Print that $15+. πŸš€ #Anktiva #SaudiHealthcare My call: $IBRX above $15 before the end of February. This is a conviction not noise. If it doesnt happen Ill run a cash giveaway by draw for followers then Ill close this account. Remember this clearly: The"  
[X Link](https://x.com/bullishbruk/status/2021353658445619533)  2026-02-10T22:40Z [----] followers, [----] engagements


"$IBRX shorts trapped in hell: 135M shares short (40%+of float) Borrow pool Ghost town only 100k850k shares left vanishing quick. CTB 8.59% and climbing bleeding shorts daily just to hold. Days to cover: [--] one spark and theyre forced to chase for a week+. Gamma ramp primed: heavy calls loading $7.50$10 strikes dealer hedging = auto-buy pressure. ANKTIVA momentum + institutions stacking + retail recalling shares = borrow spigot shutting off. Exit Zero. Plan Panic. Outcome Shorts get absolutely demolished. Hold the line smash $7.50$8 on volume cascade to $15$25+. Still short $IBRX Times up."  
[X Link](https://x.com/bullishbruk/status/2021359372761203150)  2026-02-10T23:03Z [----] followers, [----] engagements


"@SaiseiInvesting @ParhamLevi1 @YahooFinance Kkkk RS on $7 stock never heard of it. Usually RS is for stock below $1 to gain Nasdaq listing requirement"  
[X Link](https://x.com/bullishbruk/status/2021722111673610242)  2026-02-11T23:04Z [----] followers, [--] engagements


"Honestly speaking In my entire investing journey $IBRX is the first stock Ive ever genuinely hoped would dipso I could scoop up more shares on the cheap. Thats how rock-solid my confidence is in this companys long-term future. @Umbisam @alc2022"  
[X Link](https://x.com/bullishbruk/status/2018701153807024460)  2026-02-03T15:00Z [----] followers, [----] engagements


"@StockChaser_ $IBRX At least look at it.potential is there for sure"  
[X Link](https://x.com/bullishbruk/status/2020586177179570366)  2026-02-08T19:50Z [----] followers, [---] engagements


"$IBRX Everyone acts like shorts are invincible phantoms lurking in the shadows. Reality check: tons of fund managers are sniffing out weakness right now ready to pile in squeeze the bears dry and walk away with billions. I am in How about you DYOR ANKTIVA @Alhmd120690 @Umbisam https://twitter.com/i/web/status/2021945387406229964 https://twitter.com/i/web/status/2021945387406229964"  
[X Link](https://x.com/bullishbruk/status/2021945387406229964)  2026-02-12T13:52Z [----] followers, [----] engagements


"@alc2022 So much respect for ALC"  
[X Link](https://x.com/bullishbruk/status/2022001677055000592)  2026-02-12T17:35Z [----] followers, [---] engagements


"@pdsandiego @JBluePolaski_ @adamfeuerstein @DrPatrick Like I have stated every time Adam starts bashing $IBRX the stock goes up Go figure"  
[X Link](https://x.com/bullishbruk/status/2022048634829984099)  2026-02-12T20:42Z [----] followers, [---] engagements


"@IdenixH Have you checked the recent NCCN updates Might have ANKTIVA as Prefered which insurance usually cover"  
[X Link](https://x.com/bullishbruk/status/2022346802939535614)  2026-02-13T16:27Z [----] followers, [--] engagements


"$IBRX God has mercy for many and a message through DR. PSS: Glioblastoma. with this life threatening disease and for which there has been little to no advances to extend progression further and sadly early death. #Bioshield #Anktiva TO THE RESCUE @DrMakaryFDA @drkashsarabi @SecKennedy @NIHDirector_Jay @VPrasadMDMPH Please sign the petition. https://chng.it/cR6X5pFCxV Glioblastoma is medicines biggest challenge. For decades and still today the treatment involves surgery followed by radiation with chemo followed by more chemo. At the end of this [--] percent of patients have a low lymphocyte"  
[X Link](https://x.com/bullishbruk/status/1960222168446300391)  2025-08-26T06:05Z [----] followers, [----] engagements


"$IBRX Neupogen Epogen and thanks to #Anktiva soon there is going to be a therapy for Lymphocytopenia. IMO It will be a standard and part of every chemo therapy regiment and that will be Huge GLTL"  
[X Link](https://x.com/bullishbruk/status/1967779706864013502)  2025-09-16T02:36Z [----] followers, [----] engagements


"$IBRX I think @DrMakaryFDA @SecKennedy @NIHDirector_Jay knows and I believe as we speak they maybe actively working on the old guard to have a paradigm shift. If you think about it this is undeniable fact and more and more people are getting exposed to it and it will be hard for the @US_FDA just to ignore it. So it is just a matter when ANKTIVA for Lymphopenia is a done deal. must be FDA approved. Working to explain to the world how and why Bioshield works. T cells and NK cells kill cancer thats irrefutable. Low NK cells and T cells means cancer grows thats irrefutable. So if there is a drug"  
[X Link](https://x.com/bullishbruk/status/1981406693238960341)  2025-10-23T17:05Z [----] followers, [----] engagements


"$IBRX ANKTIVA dont use radiation little to no chemo but cures and kills all type of cancer tumors but @fda refuse to approve IMO they are protecting $mrk Keytruda a $32B revenue drug. @DrMakaryFDA When you live paycheck to paycheck a high copay for an expensive drug can be devastating. We are dramatically lowering drug prices. https://t.co/bFuGmHmNl7 When you live paycheck to paycheck a high copay for an expensive drug can be devastating. We are dramatically lowering drug prices. https://t.co/bFuGmHmNl7"  
[X Link](https://x.com/bullishbruk/status/1983909922036191644)  2025-10-30T14:52Z [----] followers, [----] engagements


"$IBRX @drpatrick not worried about shorts has poured $3B into @ImmunityBio and the #BioShield platform just won FDA approval for BCG-unresponsive bladder cancer (the first IL-15 superagonist). This is only the opening act. Pipeline in motion: Lung Prostate Pancreas HIV Long COVID Lymphopenia (the silent killer behind millions of chemo/radiation failures) The current price noise Manipulation. But Buying Opportunity What I see A generational opportunity. GLTL πŸš€ @alc2022 Thanks. When I developed Abraxane the stock was shorted 100percent until it got approved in [----] and Nasdaq literally had to"  
[X Link](https://x.com/bullishbruk/status/1988997586712170746)  2025-11-13T15:49Z [----] followers, [----] engagements


"$IBRX welcome to the real problem. At least this feels like a relief it wasnt only happening to us. Prasad overruled FDA staff to reject Modernas flu vaccine application https://t.co/YR7hS86BHc via @lizzylaw Prasad overruled FDA staff to reject Modernas flu vaccine application https://t.co/YR7hS86BHc via @lizzylaw"  
[X Link](https://x.com/bullishbruk/status/2021996590953902285)  2026-02-12T17:15Z [----] followers, [----] engagements


"@alc2022 In due time $DUOL $1T $HIMS $1T $IBRX $1T"  
[X Link](https://x.com/bullishbruk/status/2022062208222715940)  2026-02-12T21:36Z [----] followers, [---] engagements


"$IBRX DD Strong conviction + patience = potential life-changing moment. My price target: $65 DYOR. Not financial advice. $IBRX Weak hands are getting flushed out. I made that mistake with my [-----] options on $ASTS. Looking back I got scared out of most of my position around $5. I sold my last [----] shares at $111.00 I will not do this with$IBRX. A short squeeze is coming. $IBRX Weak hands are getting flushed out. I made that mistake with my [-----] options on $ASTS. Looking back I got scared out of most of my position around $5. I sold my last [----] shares at $111.00 I will not do this with$IBRX."  
[X Link](https://x.com/bullishbruk/status/2022347906666410386)  2026-02-13T16:31Z [----] followers, [----] engagements


"$IBRX stop loss raid Shorts last Hail Mary Remember not to long a go this was trading $1.95. Do your DD buy/sell and hold Life changing opportunities doesnt come easy @Umbisam @alc2022"  
[X Link](https://x.com/bullishbruk/status/2022404038927753451)  2026-02-13T20:14Z [----] followers, [----] engagements


"Dear Senator Moody I urge you to call on the FDAs and demand an explanation to the glaring double standard in oncology approvals. In June [----] the FDA granted Mercks Keytruda a broad tissue-agnostic approval for MSI-high tumors by pooling data from five single-arm trials. Some tumor types had only N=1 or N=2 patients different doses were used and the entire approval rested on this combined dataset (see @DrPatrick ). Merck received accelerated approval on the weakest possible evidence. Yet innovative biotechs such as ImmunityBio developing next-generation immunotherapies including IL-15"  
[X Link](https://x.com/bullishbruk/status/2022701784444113211)  2026-02-14T15:57Z [----] followers, [---] engagements


"$IBRX shorts got PLAYED. They piled in heavy on insider FDA dirtbetting on papillary rejection/delays thinking ANKTIVA was dead in the water. Then Dr. Pat drops the HAMMER: Saudi FDA slams accelerated approvals for ANKTIVA in BLADDER AND NSCLC first worldwide subQ IL-15 wins revenue exploding to 700% YoY Saudi rollout + partnerships fueling cash without waiting on FDA resub. Now: 135M+ SS borrow ZERO CTB 8-9% Trapped hemorrhaging and covering means MOONSHOT FDA curveball NahSaudi curveball nuked their thesis. One more catalyst (resub data ASCO buzz earnings beat) and this EXPLODES FOMO"  
[X Link](https://x.com/bullishbruk/status/2021936741058244995)  2026-02-12T13:17Z [----] followers, [----] engagements


"$DUOL Just added a few more I think this might be the bottom or close to it. This year my best friends are shorts They gave me $2.23 $IBRX and $112 $DUOL @alc2022 New $DUOL VP of AI. Ex Google Director of Engineering Workspace AI. https://t.co/EBErvt2M5h New $DUOL VP of AI. Ex Google Director of Engineering Workspace AI. https://t.co/EBErvt2M5h"  
[X Link](https://x.com/bullishbruk/status/2022401748057624645)  2026-02-13T20:05Z [----] followers, [----] engagements


"Dear Dr. Pat I am a stock holder and do want a return on my investment however I have a far more important reason for championing ANKTIVA: it is a genuine breakthrough that can spare patients from life-altering bladder removal give hope to those with advanced lung cancer and now reach people across the Middle East thanks to you and the Kingdoms visionary regulatory leadership. https://twitter.com/i/web/status/2022751010381312205 https://twitter.com/i/web/status/2022751010381312205"  
[X Link](https://x.com/bullishbruk/status/2022751010381312205)  2026-02-14T19:13Z [----] followers, [--] engagements


"$IBRX Anktiva PH II studyLongCovid study for all suffering #LonCovid finally meaningful remedy is on the way #bioshield We've announced our new study called COVID-4.019-Long which further expands our clinical research efforts to assess ANKTIVAs potential beyond cancer or cancer-related diseases. Learn more about the study and its potential impact: https://t.co/2Bg0U7ScFb https://t.co/1T8gLbIlZ2 We've announced our new study called COVID-4.019-Long which further expands our clinical research efforts to assess ANKTIVAs potential beyond cancer or cancer-related diseases. Learn more about the"  
[X Link](https://x.com/anyuser/status/1957802836395176389)  2025-08-19T13:52Z [----] followers, [----] engagements


"$IBRX if this news was any other biotech company the PPS would have jumped 600% just to show you how BigPharma is scared to death of #bioshield #Anktiva and keep shorting it no matter what. They must have one person at all time glued to the desk and monitoring the stock movements @drpatrick @DavidDin @drkashsarabi Weve announced that our initial data shows 100% disease control in [--] out of [--] patients with recurrent glioblastoma after being treated with our ANKTIVA NK cell therapy plus the Optune Gio device. Read more: https://t.co/Myk1ehjs7e https://t.co/nlcQMoCrvi Weve announced that our"  
[X Link](https://x.com/anyuser/status/1960349294961078617)  2025-08-26T14:31Z [----] followers, [----] engagements


"$IBRX @ImmunityBio FDA please approve #bioshield and let us get rid of #LongCovid show your support Please sign the petition https://chng.it/cR6X5pFCxV https://chng.it/cR6X5pFCxV"  
[X Link](https://x.com/anyuser/status/1961839808067625112)  2025-08-30T17:13Z [----] followers, [----] engagements


"$IBRX #Bioshield #Anktiva by @ImmunityBio getting rid of Cancer Tumors and LongCovid. @DrMakaryFDA Another inspiring story on the power of ANKTIVA Bioshield in driving NK cells even across the blood brain barrier to the brain tumor. Recurrent glioblastoma trial now open https://t.co/IA7l3lUvGi https://t.co/TrrmgEVcFO Another inspiring story on the power of ANKTIVA Bioshield in driving NK cells even across the blood brain barrier to the brain tumor. Recurrent glioblastoma trial now open https://t.co/IA7l3lUvGi https://t.co/TrrmgEVcFO"  
[X Link](https://x.com/bullishbruk/status/1963620920766960053)  2025-09-04T15:11Z [----] followers, [----] engagements


"Cute insultechoes are loudest in empty spaces. Yes I read Katherine Ebans May [----] Vanity Fair piece. Its a detailed six-month investigation interviewing nine former colleagues who dispute key parts of Calley Means backstory: his claimed direct role lobbying for Coke/Pharma clients staffing high-level meetings and being an insider whistleblower. They say he was a junior consultant not central to those accounts and his narrative got amplified for influence. His ex-mentor Steve Schmidt calls him not a whistleblower but an opportunist. Means responded by standing by his statements and dismissing"  
[X Link](https://x.com/bullishbruk/status/2006226771385983446)  2025-12-31T04:51Z [----] followers, [--] engagements


"@OccupyDemocrats Well I dont know if he owns the said equities but if he does this just proves that he is a smart businessman and definitely he doesnt mix business with politics"  
[X Link](https://x.com/bullishbruk/status/1651395609222430720)  2023-04-27T01:19Z [----] followers, 60.2K engagements


"@OccupyDemocrats At the end of the day it is all about the money. reputation my foot"  
[X Link](https://x.com/bullishbruk/status/1654537286795550720)  2023-05-05T17:23Z [----] followers, 43K engagements


"@Spriter99880 I have been saying war is not a comedy show and it is not a joke but Zelenskyy thought otherwise"  
[X Link](https://x.com/bullishbruk/status/1655248641584427009)  2023-05-07T16:30Z [----] followers, 16.1K engagements


"@nexta_tv @sharkbiotech If this continues I might volunteer to go and fight side by side with IDF I am not even a Jew"  
[X Link](https://x.com/bullishbruk/status/1718703755191882146)  2023-10-29T18:58Z [----] followers, [----] engagements


"#bioshield # ANKTIVA of @ImmunityBio $IBRX @drpatrick the great scientist go where no scientist has gone ever before The beginning of the end of Evil BigPharma. Dr. Pat THANK YOU I wil draft an X article today to discuss this finding that every [--] percent drop in NK and T cells results in [--] percent increased risk of death in lung cancer Preventable today with Bioshield since we activate NK cells with a subcutaneous jab. Your body is the factory. https://t.co/HLiCrXKkAc I wil draft an X article today to discuss this finding that every [--] percent drop in NK and T cells results in [--] percent"  
[X Link](https://x.com/bullishbruk/status/1931411301244235972)  2025-06-07T18:01Z [----] followers, [----] engagements


"A must read I call #Bioshield #Thanktiva as a #Cancer irradiator. Thank you @drpatrick $IBRX https://t.co/ATMycjbTqk https://t.co/ATMycjbTqk"  
[X Link](https://x.com/bullishbruk/status/1933981995194880419)  2025-06-14T20:16Z [----] followers, [----] engagements


"$IBRX #Bioshield #Anktiva has been approved in UK. Great news for United Kingdom MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer The Medicines and Healthcare products Regulatory Agency (MHRA) has today [--] July [----] approved nogapendekin alfa inbakicept (Anktiva) for adu https://t.co/YqVc33qMj6 MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer The Medicines and Healthcare products Regulatory Agency (MHRA) has today [--] July [----] approved nogapendekin alfa inbakicept (Anktiva) for"  
[X Link](https://x.com/bullishbruk/status/1941155361341534297)  2025-07-04T15:21Z [----] followers, 136K engagements


"And guess what multiplies these Killer cells A drug just got approved last year called #ANKTIVA #Bioshield Lymphocytes- stimulator by @ImmunityBio @drpatrick spent the last [--] years of his life and $3B of his hard earned money invented it. Instead of only for bladder cancer Hope @fda approve it for all cancer indications soon. Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. πŸ”¬ Alex Ritter / RitterLab https://t.co/sQZ7Som3V9 Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. πŸ”¬ Alex Ritter / RitterLab"  
[X Link](https://x.com/bullishbruk/status/1942762115552444872)  2025-07-09T01:45Z [----] followers, 85.3K engagements


"$IBRX bioshield (Thanktiva) the best immune stimulant to clear LongCovid it is just a no brainer. As far as safety and CR ANKTIVA has been showing strong CR and been the safest what is the @fda waiting for Need to clear and approve for all cancer tumor type and most importantly as a first line. @DrMakaryFDA please stop the old guard shenanigans protecting $MRK Keytruda and approve ANKTIVA for all tumors type now. @drpatrick @SecKennedy @NIHDirector_Jay One of the most difficult tumors to treat.glioblastoma. We will soon open a trial with @DrSimonKhagi for patients with newly diagnosed brain"  
[X Link](https://x.com/bullishbruk/status/1946959627188654287)  2025-07-20T15:45Z [----] followers, [----] engagements


"We now know mRNA vaccine is not 100% effective against COVID may even be harmful to some but according to @drpatrick (world renowned scientist surgeon) #bioshield #ANKTIVA by @ImmunityBio $IBRX is effective clearing out the spike protein (Covid/vaccine) from our body and has the ability to stimulate and strength our own God given immunity against other illness including cancer with more than [--] years safety data available. Isnt it time to authorize and clear #LongCovid @SecKennedy @DrMakaryFDA @NIHDirector_Jay @megynkelly @TuckerCarlson Dr. Patrick Soon-Shiong a pioneering surgeon and"  
[X Link](https://x.com/bullishbruk/status/1954198285234684250)  2025-08-09T15:09Z [----] followers, [----] engagements


"$IBRX I am so Happy for @GretchMick she looks amazingly healthy and happy. Congrats I believe you are on your way to be a Healthy and vibrant woman. cancer has been beaten πŸ‘ŠπŸΌBioshield Complete. 🚫 colon cancer 🚫 #cancer #coloncancer #chemo #capecitabine #bioshield #MAHA @ImmunityBio $IBRX https://t.co/yvmHfHJ1F8 πŸ‘ŠπŸΌBioshield Complete. 🚫 colon cancer 🚫 #cancer #coloncancer #chemo #capecitabine #bioshield #MAHA @ImmunityBio $IBRX https://t.co/yvmHfHJ1F8"  
[X Link](https://x.com/bullishbruk/status/1955366193268920382)  2025-08-12T20:30Z [----] followers, [----] engagements


"$IBRX now you all know why BigPharma is fighting Bioshield to keep it out of the market. Cancer cure without chemo and radiation it is just a matter of time @ImmunityBio ANKTIVA is making waves. For now BigPharma might win the battle but eventually $IBRX will win the war @drpatrick @DrMakaryFDA $IBRX ImmunityBio sees successful outcomes in Non-Hodgkin Waldenstrom Lymphoma patients using CD19 CAR-NK immunotherapy without chemotherapy. More Info: https://t.co/8dCoyPjezS $XBI $IBB $XPH $PPH https://t.co/vtch0GK1Mi $IBRX ImmunityBio sees successful outcomes in Non-Hodgkin Waldenstrom Lymphoma"  
[X Link](https://x.com/bullishbruk/status/1955619181413425533)  2025-08-13T13:15Z [----] followers, [----] engagements


"$IBRX with more good news BigPharma is doubling down and shorting IBRX to death. now 85% 80M+ shorted shares. Sooner or later they have to cover and meantime we are accumulating. The time is on our side. Patience PT $65"  
[X Link](https://x.com/bullishbruk/status/1955623834910105785)  2025-08-13T13:33Z [----] followers, [----] engagements


"$IBRX the power of #Bioshield all its waiting for is a complete paradigm shift and the beginning of the end of cancer and let us not forget that the current president is @realDonaldTrump this will never happened with any other president. Big Thank you to @POTUS @DrMakaryFDA @SecKennedy The power of NK cells. After a single cycle of NK cells targeting the tumor the patient with a rare lymphoma (WM) [---] percent of bone marrow infiltrated ( left PET scan) achieved a COMPLETE RESPONSE ( right scan). Had failed all other therapy. The power of the BIOSHIELD platform. https://t.co/a6ZWSoWzJX The"  
[X Link](https://x.com/bullishbruk/status/1955657246312169801)  2025-08-13T15:46Z [----] followers, [----] engagements


"$IBRX Longs this is the kind of tweet that makes you be proud of your investment in the company. But we need to get #Bioshield approved and so many can be saved. While BigPharmas get keeper @US_FDA playing games we are running out of time. Please sign the petition. https://chng.it/cR6X5pFCxV Patient would like me to share this wonderful response to the Bioshield. from not being able to speak clearly because of tumor to now singing his song in our clinic. What a blessing. https://t.co/fLrnBT1HYC https://chng.it/cR6X5pFCxV Patient would like me to share this wonderful response to the Bioshield."  
[X Link](https://x.com/bullishbruk/status/1959359389808107735)  2025-08-23T20:57Z [----] followers, [----] engagements


"$IBRX #Bioshield couldnt repost it enough The message needs to be out repeatedly so everyone can experience a paradigm shift. We need it Huge Thanks to @newstart_2024 he is doing his part. Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's a devastating paradox at the heart of modern cancer care. As articulated by Dr. Patrick Soon-Shiong we are systematically poisoning the body's single most powerful https://t.co/DzjEcfAZGF Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's"  
[X Link](https://x.com/bullishbruk/status/1959663005261603112)  2025-08-24T17:04Z [----] followers, [----] engagements


"$IBRX GretchMick: because of #Anktiva #Bioshield I believe I am cancer free GretchMick Congrats So happy for you @US_FDA @drpatrick @DrMakaryFDA @SecKennedy @NIHDirector_Jay @POTUS @elonmusk Post Bioshield Test Results #cancersurveillance #cancer #coloncancer #chemo #bioshield $IBRX @ImmunityBio @CCAlliance https://t.co/LpEXPqTswt Post Bioshield Test Results #cancersurveillance #cancer #coloncancer #chemo #bioshield $IBRX @ImmunityBio @CCAlliance https://t.co/LpEXPqTswt"  
[X Link](https://x.com/bullishbruk/status/1960071398837403705)  2025-08-25T20:06Z [----] followers, [----] engagements


"$IBRX chemo and radiation therapy to kill cancer tumor is like "cut off your nose to spite your face" because it will wipe out your immune system. A new therapy #bioshield #Anktiva by @ImmunityBio with little or no chemo kills all type of Cancer tumors and clears LongCovid just by stimulating and energizing your own God given immune system"  
[X Link](https://x.com/bullishbruk/status/1960229519643525572)  2025-08-26T06:35Z [----] followers, [----] engagements


"$IBRX Alan congratulations We appreciate you sharing your experience with #Bioshield #Anktiva success story. Thank you @drpatrick @DrMakaryFDA @SecKennedy @bullishbruk @US_FDA @drpatrick @DrMakaryFDA @SecKennedy @NIHDirector_Jay @POTUS @elonmusk Thank you for sharing I am another successful story as N=1 prostate cancer patient and complete response (cancer free) to BioShield combined with localized radiation. My story coming up on video soon. CONGRATULATIONS @bullishbruk @US_FDA @drpatrick @DrMakaryFDA @SecKennedy @NIHDirector_Jay @POTUS @elonmusk Thank you for sharing I am another successful"  
[X Link](https://x.com/bullishbruk/status/1960330978066366870)  2025-08-26T13:18Z [----] followers, [----] engagements


"$IBRX is @fda waiting till most Glioblastoma patients are dead Let us look ANKTIVA is clear for safety and approved with 10+ years worth of safety data. Why wait on terminal disease such cancer especially Glioblastoma @DrMakaryFDA needs to expedite the approval as soon as possible. Many needs Bioshield now Weve announced that our initial data shows 100% disease control in [--] out of [--] patients with recurrent glioblastoma after being treated with our ANKTIVA NK cell therapy plus the Optune Gio device. Read more: https://t.co/Myk1ehjs7e https://t.co/nlcQMoCrvi Weve announced that our initial data"  
[X Link](https://x.com/bullishbruk/status/1960336835705446525)  2025-08-26T13:41Z [----] followers, [----] engagements


"$IBRX the pix says a lot If this is not a cure I dont know what it is. #Bioshield #Anktiva @ImmunityBio Initial data shows [--] patients with near Complete Response & 100% disease control in first [--] patients. When the immune system is protected CR in tumors difficult to treat in recurrent GBM is possible. GBM trial open at https://t.co/wwLWOlBYtC Data for lung cancer next #WCLC25 https://t.co/wdCDGQ1zhf Initial data shows [--] patients with near Complete Response & 100% disease control in first [--] patients. When the immune system is protected CR in tumors difficult to treat in recurrent GBM is"  
[X Link](https://x.com/bullishbruk/status/1960407477079494827)  2025-08-26T18:22Z [----] followers, [----] engagements


"$IBRX a prophecy #ANKTIVA is going to be huge. you know when you are in the know thanks ANKTIVA. Remember that word/therapy. ANKTIVA. Remember that word/therapy"  
[X Link](https://x.com/bullishbruk/status/1961118169508065756)  2025-08-28T17:26Z [----] followers, [----] engagements


"$IBRX "BioShield" (ANKTIVA) @drpatrick The BioShield is not a vaccine in the traditional sense but rather an immunotherapy designed to restore and activate the patient's own immune system to fight cancer and potentially other infections like Long COVID. It works by stimulating Natural Killer (NK) and T cells which are critical for a patient's immune response. IT CLEARS LongCovid @SecKennedy @peterthiel @NIHDirector_Jay @DrMakaryFDA"  
[X Link](https://x.com/bullishbruk/status/1961788545946746940)  2025-08-30T13:50Z [----] followers, [----] engagements


"$IBRX if you are a cancer patient or suffering from LongCovid you should read this and ask questions. It is your life or death @US_FDA @DrMakaryFDA Dr. P.S.S: Next week we will share our data in [--] patients with lung cancer who failed chemo and some who failed both chemo and radiation.But why are we waiting to catch patients once they already in a deep hole Why not protect their cells from the outset @VPrasadMDMPH @POTUS @SecKennedy @NIHDirector_Jay Next week we will share our data in [--] patients with lung cancer who failed chemo and some who failed both chemo and radiation and all [--] who"  
[X Link](https://x.com/bullishbruk/status/1961997405055815841)  2025-08-31T03:40Z [----] followers, [----] engagements


"$IBRX it is time for @drpatrick to come out and publicly expose Francis Collins (then NIH director) and Tony Fauci what both did to exclude the only therapy that cleared COVID virus form our body #Bioshield ANKTIVA by @ImmunityBio from warp speed in [----]. @RealAlexJones @newstart_2024 @realDonaldTrump @RWMaloneMD"  
[X Link](https://x.com/bullishbruk/status/1962585028707127296)  2025-09-01T18:35Z [----] followers, [----] engagements


"$IBRX #Bioshield This great news is a Labor Day gift not only for Lung-cancer patients but a hope for all type of cancer patients including people suffering from LongCovid. Long live Dr. PSS. Thank you @adamfeuerstein @drkashsarabi @DrMakaryFDA @RWMaloneMD NCI supported PRAGMATICA lung trial failed but established real world survival after chemo of [--] mo. Our Bioshield trial in lung patients who progressed show when NK & T cells are activated survival is doubled & some patients live 4+ yrs in late stage of cancer Coming this week https://t.co/O1ysbaJyV5 NCI supported PRAGMATICA lung trial"  
[X Link](https://x.com/bullishbruk/status/1962608439886004691)  2025-09-01T20:08Z [----] followers, [----] engagements


"$IBRX there is only one remedy to clear COVID and mRNA vaccine from our body that is #bioshield #ANKTIVA by @drpatrick BARDA need to fund @ImmunityBio NOW"  
[X Link](https://x.com/bullishbruk/status/1962630775972512147)  2025-09-01T21:36Z [----] followers, [----] engagements


"$IBRX David Excellent The companys PR department needs to hire you. Thank you #Anktiva #Bioshield NEW CANCER DRUG ANKTIVA STRONGLY INCREASES OVERALL SURVIVAL OF TERMINAL LUNG CANCER PATIENTS Data from a completed clinical trial shows that lung cancer patients who have failed all FDA approved optionschemo radiation and checkpoint inhibitorsand have no more treatments https://t.co/WeFtS5L5jE NEW CANCER DRUG ANKTIVA STRONGLY INCREASES OVERALL SURVIVAL OF TERMINAL LUNG CANCER PATIENTS Data from a completed clinical trial shows that lung cancer patients who have failed all FDA approved"  
[X Link](https://x.com/bullishbruk/status/1964300179458134021)  2025-09-06T12:10Z [----] followers, [----] engagements


"$IBRX Lung Cancer patients survival tripled (7months vs 21Months) with #Bioshield #Anktiva a $50B+ company in the making Weve announced new paradigm-changing findings from the Phase [--] QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural killer and T cells) in patients with checkpoint inhibitor-resistant advanced non-small cell lung cancer https://t.co/aTxCJgqQnZ Weve announced new paradigm-changing findings from the Phase [--] QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural"  
[X Link](https://x.com/bullishbruk/status/1965045360923226157)  2025-09-08T13:31Z [----] followers, [----] engagements


"$IBRX we had one of the best news of LunCancer triples survival vs current therapy and we go down $2.35 like the drug killed somebody it is just obvious IMO @drpatrick should hire a PI and find out who is manipulating the stock IMO one of the BigPharma like $MRK maybe doing it"  
[X Link](https://x.com/bullishbruk/status/1965050777434747222)  2025-09-08T13:53Z [----] followers, [----] engagements


"$IBRX #bioshield #Anktiva paradigm shifts slowly but surely Oncologists from Ohio State at WCLC25 demonstrate that absolute lymphocyte count (ALC) matters. When lymphocytes are recovered the survival rate is doubled to [-----] months The cancer world is waking up to the concept of ALC and how chemo-radiation destroys our NK and T cells. https://t.co/g6FJTvwLpI Oncologists from Ohio State at WCLC25 demonstrate that absolute lymphocyte count (ALC) matters. When lymphocytes are recovered the survival rate is doubled to [-----] months The cancer world is waking up to the concept of ALC and how"  
[X Link](https://x.com/bullishbruk/status/1965164744031306025)  2025-09-08T21:26Z [----] followers, [----] engagements


"$IBRX so happy to hear so far @GretchMick is cancer free #bioshield #anktiva @DrMakaryFDA @POTUS @SecKennedy @NIHDirector_Jay @drpatrick CT Scan Results #coloncancer #cancer @ImmunityBio #bioshield https://t.co/daqrsIAyVH CT Scan Results #coloncancer #cancer @ImmunityBio #bioshield https://t.co/daqrsIAyVH"  
[X Link](https://x.com/bullishbruk/status/1965192492959367366)  2025-09-08T23:16Z [----] followers, [----] engagements


"$IBRX Thanks to @drpatrick promoting #Bioshield #Anktiva has been successful and soon many patients will request it and Doctors will have to prescribe it for all cancer tumor type including LongCovid. A $50B+ MC company in the making I think most people miss one thing about $IBRX ANKTIVA (N-803) isnt just a bladder cancer drug its an immune system drug so the potential is huge to target a multitude of cancers. A lot of patients and doctors start to understand it that's why ImmunityBio receives so many I think most people miss one thing about $IBRX ANKTIVA (N-803) isnt just a bladder cancer"  
[X Link](https://x.com/bullishbruk/status/1966132458899808557)  2025-09-11T13:31Z [----] followers, [----] engagements


"$IBRX unlimited opportunity $2.4B MC is a joke. I say $24B+MC for starter and in due time this company should be a $100B+ MC. Invest wisely do your DD. The future is here. Cell therapy especially CAR-NK therapy is the next era of cancer care. Especially when you combine cell therapy w cytokines such as ANKTIVA. Amassing cancer killer cells @ImmunityBio Waldenstrom trial open at https://t.co/wwLWOlBYtC https://t.co/ReBX8DHoje The future is here. Cell therapy especially CAR-NK therapy is the next era of cancer care. Especially when you combine cell therapy w cytokines such as ANKTIVA. Amassing"  
[X Link](https://x.com/bullishbruk/status/1967586383083749719)  2025-09-15T13:48Z [----] followers, [----] engagements


"$IBRX #Bioshield is the one that cleared both COVId and mRNA vaccine spike protein. FDA approvals needed @SecKennedy @DrMakaryFDA RIP Charlie Kirk. Renowned surgeon & scientist Dr. Patrick Soon-Shiong delivered a chilling warning to Charlie Kirk and his audience: The world was facing a global pandemic of "turbo cancers" in young people. The anecdotal evidence had become a terrifying medical reality. Cancer https://t.co/pBuP7hFml0 RIP Charlie Kirk. Renowned surgeon & scientist Dr. Patrick Soon-Shiong delivered a chilling warning to Charlie Kirk and his audience: The world was facing a global"  
[X Link](https://x.com/bullishbruk/status/1968277732422484331)  2025-09-17T11:35Z [----] followers, [----] engagements


"$IBRX #bioshield international exposure Inspiring to see patients receiving cellular therapies here in Riyadh. Looking forward to seeing future possibilities with our #BioShield at King Faisal Specialist Hospital & Research Centre #SaudiUSForum2025 @MISA @Saudi_FDA https://t.co/8iYTlwPzIe Inspiring to see patients receiving cellular therapies here in Riyadh. Looking forward to seeing future possibilities with our #BioShield at King Faisal Specialist Hospital & Research Centre #SaudiUSForum2025 @MISA @Saudi_FDA https://t.co/8iYTlwPzIe"  
[X Link](https://x.com/bullishbruk/status/1968289928669966647)  2025-09-17T12:24Z [----] followers, [----] engagements


"$IBRX @NIHDirector_Jay @DrJBhattacharya searching for #LongCovid therapy how about speaking to @drpatrick #Bioshield is available and it will get rid of both Covid and mRNA spike proteins .@NIHDirector_Jay: A Long COVID patient came up to me and said Im desperate please help and I assured her that were going to find an answer. https://t.co/d5X4dCleDO .@NIHDirector_Jay: A Long COVID patient came up to me and said Im desperate please help and I assured her that were going to find an answer. https://t.co/d5X4dCleDO"  
[X Link](https://x.com/bullishbruk/status/1968779584901353874)  2025-09-18T20:50Z [----] followers, [----] engagements


"$IBRX paradigm shift is taking place it just a matter of time #bioshield will be approved by @fda to treat Lymphopenia and every time people gets a chemo/radiation treatments they have to take ANKTIVA to boost their NK cells A landmark publication at ASCO [----] has finally acknowledged the unthinkable: radiation therapy can induce metastasis spreading the cancer it was meant to treat. This is the seismic shift in oncology revealed by Dr. Patrick Soon-Shiong. The largest gathering of global https://t.co/A5W7WzAGx0 A landmark publication at ASCO [----] has finally acknowledged the unthinkable:"  
[X Link](https://x.com/bullishbruk/status/1975365531122516249)  2025-10-07T01:00Z [----] followers, [----] engagements


"Well how about approving Bioshield (ANKTIVA) for Lymphopenia I am sure you know @drpatrick talk to him Harnessing AI to make America healthy again By Marty Makary Jim O'Neill Imagine what would happen if the government put Boeing in charge of airline safety or if fast-food chains set national nutrition standards. Such an irony took place when then-President Joe Biden allowed Harnessing AI to make America healthy again By Marty Makary Jim O'Neill Imagine what would happen if the government put Boeing in charge of airline safety or if fast-food chains set national nutrition standards. Such an"  
[X Link](https://x.com/bullishbruk/status/1976334121719996503)  2025-10-09T17:09Z [----] followers, [----] engagements


"$IBRX Queen Megyn absolutely His legacy depending on it and definitely the Nobel Prize will be in the bag This should be available for the rest of the country @drpatrick on why he believes Trump can implement his plan to prevent and cure cancer. Watch and download: https://t.co/F96HgI7HIW https://t.co/QXv4nBM14A This should be available for the rest of the country @drpatrick on why he believes Trump can implement his plan to prevent and cure cancer. Watch and download: https://t.co/F96HgI7HIW https://t.co/QXv4nBM14A"  
[X Link](https://x.com/bullishbruk/status/1976400863519481986)  2025-10-09T21:34Z [----] followers, [----] engagements


"It amazes me that here we have #bioshield ANKTIVA already available doing almost the same thing but people ignoring it and looking the other way if #bioshield was presented by BigPharma instead of @drpatrick everyone including @ScottAdamsSays would have called it a breakthrough and a miracle of the century. @newstart_2024 @megynkelly @TuckerCarlson @Rainmaker1973 @seanspicer Next-gen vaccine prevents up to 88% of multiple aggressive cancers Paul McClure New Atlas A next-generation cancer vaccine has shown stunning results in mice preventing up to 88% of aggressive and difficult-to-treat"  
[X Link](https://x.com/bullishbruk/status/1977051596539273643)  2025-10-11T16:40Z [----] followers, [----] engagements


"Once again @DrMakaryFDA @SecKennedy @DrJBhattacharya @realDonaldTrump #CancerCure Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with long-term survival regardless of tumor types. Current https://t.co/Lczvpeqc6z Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with"  
[X Link](https://x.com/bullishbruk/status/1977818755813286026)  2025-10-13T19:28Z [----] followers, [----] engagements


"#Bioshield #Anktiva a #cancercure that @US_FDA holding hostage @RealAlexJones @newstart_2024 @Rainmaker1973 @VigilantFox @megynkelly @seanspicer @TuckerCarlson Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with long-term survival regardless of tumor types. Current https://t.co/Lczvpeqc6z Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating"  
[X Link](https://x.com/bullishbruk/status/1977819839373984115)  2025-10-13T19:32Z [----] followers, [----] engagements


"Cancer therapy breakthrough It is not mRNA Chemo nor Radiation @drpatrick Bioshield stimulate and boosts your own God given immune system fight and get rid of every types of cancer. A Cancer Breakthrough That Changes Everything In a stunning medical advance Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancersincluding brain pancreatic and head & neck tumorsafter all other treatments https://t.co/0njJPLM0yb A Cancer Breakthrough That Changes Everything In a stunning medical advance Dr. Patrick Soon-Shiong reveals a platform"  
[X Link](https://x.com/bullishbruk/status/1978246134586843317)  2025-10-14T23:46Z [----] followers, [----] engagements


"$IBRX Proven in clinics: BCG-unresponsive NMIBC ANKTIVA + BCG hit 71% complete response rate (vs. 0% historical). Now expanding: Phase [--] trials show lymphopenia reversal in lung/prostate cancers improving PFS by 30-40%. FDA Expanded Access in June '25. #NMIBC #BladderCancer"  
[X Link](https://x.com/bullishbruk/status/1978401063246979390)  2025-10-15T10:02Z [----] followers, [----] engagements


"Let that sink in It's wild: A patient will bravely endure chemo's harsh effects but the suggestion to cut sugar eat clean and detox is treated as radical unscientific nonsense. The conditioning is real. It's wild: A patient will bravely endure chemo's harsh effects but the suggestion to cut sugar eat clean and detox is treated as radical unscientific nonsense. The conditioning is real"  
[X Link](https://x.com/bullishbruk/status/1978421655895503356)  2025-10-15T11:24Z [----] followers, [----] engagements


"$IBRX meeting at EMA (fda for EU) today is the last day of the monthly [--] days long meeting and ANKTIVA is on the agenda"  
[X Link](https://x.com/bullishbruk/status/1978824454105866263)  2025-10-16T14:04Z [----] followers, [----] engagements


"$IBRX wouldnt be nice if we can get IVM and Bioshield combined as a cancer cure regiment approved and available worldwide Other IVMs anti-cancer mechanisms of action: Inhibits tumor growth/proliferation Inhibits tumor initiation/progression Regulates tumor micro-environment Causes cancer cell mitochondrial dysfunction Stops cancer cell migration invasion & metastasis https://t.co/ZBGkMolN2e Other IVMs anti-cancer mechanisms of action: Inhibits tumor growth/proliferation Inhibits tumor initiation/progression Regulates tumor micro-environment Causes cancer cell mitochondrial dysfunction Stops"  
[X Link](https://x.com/bullishbruk/status/1978872962737488275)  2025-10-16T17:17Z [----] followers, [----] engagements


"$IBRX #BIoshield a road map to a meaningful cancer cure without the usual chemo/radiations nasty and debilitating side effects After [--] years of unraveling cancer's diabolical nature Dr. Patrick Soon-Shiong reveals a paradigm shift: We've been fighting cancer all wrong. The old war of attrition with high-dose chemo and radiation is failing. Cancer is a clever adaptive entity that hides from our immune https://t.co/enGT037VHa After [--] years of unraveling cancer's diabolical nature Dr. Patrick Soon-Shiong reveals a paradigm shift: We've been fighting cancer all wrong. The old war of attrition"  
[X Link](https://x.com/bullishbruk/status/1978937521292685625)  2025-10-16T21:34Z [----] followers, [----] engagements


"I have a feeling #bioshield ANKTIVA for LongCovid or Lymphopenia is going to be on the next list FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability domestic production or meeting an unmet public health need. https://t.co/oUuEsAnBQ2 FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability domestic production or meeting an unmet public health need. https://t.co/oUuEsAnBQ2"  
[X Link](https://x.com/bullishbruk/status/1978955757799239841)  2025-10-16T22:46Z [----] followers, [----] engagements


"$IBRX ANKTIVA TO HE RESCUE A peer-reviewed Italian study reveals a shocking spike in cancer rates following COVID-19 vaccination. Hazard Ratios at 6-month follow-up: ➠ Breast Cancer: +54% ➠ Bladder Cancer: +62% ➠ Colorectal Cancer: +34% As noted by Dr. John Campbell this is the critical data the https://t.co/vuvVCHNQ8C A peer-reviewed Italian study reveals a shocking spike in cancer rates following COVID-19 vaccination. Hazard Ratios at 6-month follow-up: ➠ Breast Cancer: +54% ➠ Bladder Cancer: +62% ➠ Colorectal Cancer: +34% As noted by Dr. John Campbell this is the critical data the"  
[X Link](https://x.com/bullishbruk/status/1981475858490503329)  2025-10-23T21:40Z [----] followers, [----] engagements


"$IBRX $IBRX is the company that could save the world 🧡 https://t.co/uvWSujlLOM $IBRX is the company that could save the world 🧡 https://t.co/uvWSujlLOM"  
[X Link](https://x.com/bullishbruk/status/1981787218000978421)  2025-10-24T18:17Z [----] followers, 30.2K engagements


"$IBRX Lymphopenia is going to have a therapy and it is going to be none other than BIOSHIELD ANKTIVA. World wide market is huge $500B+ and so far you only have ANKTIVA. PT $65 Wow. Finally the dots are connecting Great thread. My greatest fear seems to be playing out .Covid has immunosuppressed millions of lives and tumors ( even rare cancers) that were in remission are now re-occurring. Lymphocytes matter. ALC matters. I will begin a thread again Wow. Finally the dots are connecting Great thread. My greatest fear seems to be playing out .Covid has immunosuppressed millions of lives and"  
[X Link](https://x.com/bullishbruk/status/1982116387473551590)  2025-10-25T16:05Z [----] followers, [----] engagements


"$IBRX @RobSchneider Dr. Patrick Soon-Shiong isnt Big Pharmahes fighting it. [--] yrs & billions later his ANKTIVA (the Cancer BioShield) got FDA approval but ONLY for BCG-unresponsive bladder cancer after chemo/radiation fails. It reverses lymphopenia boosts NK/T cells and shows promise across solid tumors + Long COVID trials. Yet broader use is blocked. Oncology market $200B+. Coincidence @ImmunityBio #ANKTIVA #CancerBioShield"  
[X Link](https://x.com/bullishbruk/status/1983348008029692316)  2025-10-29T01:39Z [----] followers, [----] engagements


"Urgent Call to Action: Free #Bioshield #ANKTIVA from FDA Delays and Save Cancer Patients Lives. Dear @CalleyPoche and @DrMakaryFDA @US_FDA Leadership Every day that #ANKTIVA remains trapped in regulatory limbo is another day cancer patients are denied a proven life-extending therapy. #Bioshield the innovative immunotherapy behind ANKTIVA has already demonstrated remarkable efficacy in clinical trialsdelivering complete remissions in high-risk BCG-unresponsive bladder cancer patients where no other options exist. This isnt experimental hope; its validated science backed by peer-reviewed data"  
[X Link](https://x.com/bullishbruk/status/1984656777355428233)  2025-11-01T16:20Z [----] followers, [----] engagements


"$IBRX @alc2022 NK cells could extend your life (NK) Natural Killer Cells Matte ANKTIVA will be the #1 go to therapy 🧬 NK CELLS MATTER Cientficos revelan que pacientes con bajos niveles de linfocitos (linfopenia) tienen menor supervivencia sin importar el tipo de cncer. La nueva terapia Anktiva activa las clulas NK y T revirtiendo esta deficiencia y fortaleciendo el sistema inmune - FDA https://t.co/an8FKso7EM 🧬 NK CELLS MATTER Cientficos revelan que pacientes con bajos niveles de linfocitos (linfopenia) tienen menor supervivencia sin importar el tipo de cncer. La nueva terapia Anktiva"  
[X Link](https://x.com/bullishbruk/status/1984699505208373472)  2025-11-01T19:10Z [----] followers, [----] engagements


"$IBRX DR.Pat Sir that is a great news We need @ScottAdamsSays to stay with us a bit longer His unique wisdom is irreplaceable. Scott we can add Anktiva to Pluvicto and have exciting data in Prostate cancer. Please reach out to the clinic @cssifm and we will help you. Raising your NK and T cells can change the course. We have to apply to FDA one patient at a time. But will get that done. Details Scott we can add Anktiva to Pluvicto and have exciting data in Prostate cancer. Please reach out to the clinic @cssifm and we will help you. Raising your NK and T cells can change the course. We have"  
[X Link](https://x.com/bullishbruk/status/1985084107265605639)  2025-11-02T20:38Z [----] followers, [----] engagements


"$IBRX Keytruda FDA approvals from single-arm trials but not ANKTIVA why @DrMakaryFDA is it fair Heres the rundown [--]. HNSCC Aug [--] [----] [--]. cHL (R/R adults): May [--] [----] [--]. cHL (peds [--] pr): Oct [--] [----] [--]. PMBCL Jun [--] [----] [--]. Urothelial May [--] [----] [--]. NMIBC (BCG-unresp w/CIS): Jan [--] [----] [--]. MSI-H/dMMR May [--] [----] [--]. HCC (HBV): Nov [--] [----] [--]. MCC Dec [--] [----] [--]. cSCC Jun [--] [----] [--]. TMB-H solids Jun [--] [----] [--]. Endometrial (adv MSI-H/dMMR post-tx): Jun [--] [----] [--]. RCC non-clear cell Aug [----] (est.) [--]. Urothelial (w/enfortumab vedotin plat-ineligible): Dec [----] Many acceleratedconfirmatory trials"  
[X Link](https://x.com/bullishbruk/status/1985987143143989269)  2025-11-05T08:26Z [----] followers, [----] engagements


"$IBRX Pray for Scott Adams He started his Pluvicto and Thanks to @drpatrick apparently he is going to do Bioshield as well. Smart Man Scott Adams medical update Yesterday he completed the first of six rounds of Pluvicto which will take several months and has a one in three chance of working. In addition to this he will be doing BioShield. Please continue to pray for Scott https://t.co/cBB4AiQc5s Scott Adams medical update Yesterday he completed the first of six rounds of Pluvicto which will take several months and has a one in three chance of working. In addition to this he will be doing"  
[X Link](https://x.com/bullishbruk/status/1986211379934544122)  2025-11-05T23:17Z [----] followers, [----] engagements


"@jayplemons I am very happy he started his treatment and extra excited he started ANKTIVA Bioshield. I have a feeling he is going to beat it"  
[X Link](https://x.com/bullishbruk/status/1986216791950172433)  2025-11-05T23:39Z [----] followers, [----] engagements


"$IBRX ANKTIVA: FDA-approved for bladder cancer reverses lymphopenia in 80% saves lives via Expanded Access. Yet full approval to fix cancers #1 killer (immune collapse) is BLOCKED. Same FDA that crushed $QURE. Small biotech = death by bureaucracy. @WSJopinion RUN THIS: FDAs War on Wonder Drugs Patients dying. UK approved. Trump/Kennedy HHSdrain the swamp NOW. #ANKTIVA #MAHA"  
[X Link](https://x.com/bullishbruk/status/1986731022377943461)  2025-11-07T09:42Z [----] followers, [----] engagements


"$IBRX ANKTIVA: reverses lymphopenia in 80% saves lives via Expanded Access. Yet full approval to fix cancers #1 killer (immune collapse) is BLOCKED. death by bureaucracy. @WSJopinion RUN THIS: FDAs War on Wonder Drugs Patients are dying. The FDA is making news for all of the wrong reasons and the dysfunction could have life and death consequences for patients. https://t.co/aHDBYUMbam The FDA is making news for all of the wrong reasons and the dysfunction could have life and death consequences for patients. https://t.co/aHDBYUMbam"  
[X Link](https://x.com/bullishbruk/status/1986740765687509475)  2025-11-07T10:21Z [----] followers, [----] engagements


"Massive undeniable catalyst in biotechnology: a true cancer cure that skips chemo entirely IMO $IBRX is about to pull the exact same move as $QMMM did from $2.08 $303. The question isnt if its when. Patience pays πŸš€πŸ’‰"  
[X Link](https://x.com/bullishbruk/status/1987170372383601134)  2025-11-08T14:48Z [----] followers, [----] engagements


"Im long [--] stocks but rarely talk about any except $IBRX. Thanks to @drpatrick I know what ANKTIVA is truly capable of. If my mom were still here it couldve saved her. Nothing would make me happier than seeing ANKTIVA fully approved for Lymphopenia and millions of cancer patients finally getting the lifeline they deserve. πŸš€πŸ™ #ANKTIVA"  
[X Link](https://x.com/bullishbruk/status/1987241125782974552)  2025-11-08T19:29Z [----] followers, [----] engagements


"$IBRX @adamfeuerstein Please take a moment to read Dr. PSSs response to Marys inquiry. Youll notice a clear difference: Dr. PSS provides a detailed evidence-based answer genuinely aimed at advancing scientific understanding and patient care while your earlier gotcha question seemed more focused on controversy than progress. Constructive dialogue moves the field forward. Hope this is helpful. #Anktiva #Bioshield @alc2022 Thanks for the thoughtful questions Mary. Youre absolutely rightALC is a powerful prognostic marker and weve now demonstrated across [--] tumor types including lung cancer that"  
[X Link](https://x.com/bullishbruk/status/1987582443403059407)  2025-11-09T18:05Z [----] followers, [----] engagements


"$IBRX ultraBullish case @alc2022 $IBRX ANKTIVA dominates lymphopenia reset Reverses low lymphocytes rescues checkpoints in 70%+ cancers Long COVID cure-all Phase [--] data [----] = $100B+ market capture (65M+ patients globally) Spike protein cancer explosion Post-COVID oncology boom; ANKTIVA as universal Bioshield Pipeline nukes competition NSCLC BLA [----] GBM lymphoma HIV $20B+ peak sales M&A or mega-partner Big Pharma pays $200B+ premium to own IL-15 platform Shares 985M $100B MC = $101/share (50x from $2) Dilution Always there but could be supported by Cash runway + revenue explosion funds"  
[X Link](https://x.com/bullishbruk/status/1987649441067684260)  2025-11-09T22:32Z [----] followers, [----] engagements


"$IBRX #Bioshield #Anktiva I am so happy for GretchMick She updates her [--] months post Bioshield status and so far so good @LoriMills4CA42 @drpatrick @DrMakaryFDA @ScottAdamsSays @SecKennedy @alc2022 [--] months Post BioShield Update πŸ‘ŠπŸΌ#Bioshield #cancer #coloncancer #lymphopenia #ALC @drpatrick $IBRX https://t.co/6Se7ei1pqb [--] months Post BioShield Update πŸ‘ŠπŸΌ#Bioshield #cancer #coloncancer #lymphopenia #ALC @drpatrick $IBRX https://t.co/6Se7ei1pqb"  
[X Link](https://x.com/bullishbruk/status/1987983545596580103)  2025-11-10T20:39Z [----] followers, [----] engagements


"🚨 BREAKING THE CANCER MATRIX 🚨 Yo @elonmusk @JoeRogan bring @drpatrick on the pod RIGHT NOW Were DONE with chemo & radiation that fail 90%+ of patients and destroy lives. BioShield is the paradigm-shifting nuclear option weve all been waiting for an actual immune BIOSHIELD thats saving people BIG TIME. Whos ready to end cancer in our lifetime πŸ”₯πŸ”₯πŸ”₯ Tag everyone. Retweet if you want this convo to go VIRAL. $IBRX #ANKTIVARevolution #BioShieldRevolution #CancerKiller #EndChemoEra"  
[X Link](https://x.com/bullishbruk/status/1988044746481103137)  2025-11-11T00:42Z [----] followers, [----] engagements


"$IBRX πŸ’” ANKTIVA vs CHEMO/RAD πŸ’” #Bladdercancer #pancreascancer #LungCancer #ProstateCancer Chemo: POISONS your body. KILLS your immune army (500). Leaves families broken. ANKTIVA: **IGNITES 10000+ WARRIORS** inside you. Spares your hair your strength your HOPE. 70% CURE when all else failed. One steals life. One **GIVES IT BACK**. STOP THE SUFFERING. CHOOSE ANKTIVA. #oncologists #Hospitals #urologists #Pharmacists #AnktivaForTheFighters #NoMoreTears @ImmunityBio #Bioshield"  
[X Link](https://x.com/bullishbruk/status/1988513659249659945)  2025-11-12T07:46Z [----] followers, [----] engagements


"$IBRX #Bioshield #ANKTIVA @drpatrick Just wrapped a πŸ”₯ riveting session with oncologists & results of patientsirrefutable proof ANKTIVA supercharges NK/T cells to ERADICATE cancer πŸ’₯ One-hour special w/ doctors & miracle outcomes airing SOON πŸ“Ίβœ¨ We the public Eagerly awaiting FDA green-light for ALL indications πŸš€ Hope is SOARING 🌟With urgency & optimism πŸ™Œ @DrMakaryFDA @VPrasadMDMPH @NIHDirector_Jay Just completed a long discussion about the results of patients receiving Anktiva to expand their NK cells and T cells. It is irrefutable that NK and T cells are key immune cells that kill"  
[X Link](https://x.com/bullishbruk/status/1989730495463030948)  2025-11-15T16:21Z [----] followers, [----] engagements


"$IBRX This is our mission: secure FDA approval for ANKTIVA across all indicationsno delays no denials no bureaucratic mercy. Jeff Rose a proud American battling stage [--] prostate cancer deserves to walk into his doctors office and receive this life-saving therapy today. @DrMakaryFDA @FDAAre you listening APPROVE ANKTIVA NOW. @JeffRoseTV πŸ’ͺ @drpatrick Thank you for all youre doing Dr. Soon-Shiong. I have been praying for my friend @LoriMills4CA42 and her husband. Im so grateful you are able to help them. I too am hoping you can help me. I am stage [--] metastatic prostate cancer. Ive been on"  
[X Link](https://x.com/bullishbruk/status/1989756319549526146)  2025-11-15T18:04Z [----] followers, [----] engagements


"$IBRX Did you realize your very life depends on your immune systemthe one thats quietly crumbling from age junk food couch-potato days and every ailment youve battled Even if youre already doing everything right ANKTIVA can explode your immunity 300%+ locking in youthful energy unbreakable vitality and the power to outrun time itself. The FDA has already proven ANKTIVAs safety and efficacy in BCG-unresponsive bladder cancerpatients who were out of options are now cancer-free and thriving. Thats not hype; thats Level [--] evidence. With a mechanism that supercharges NK cells and T-cells across"  
[X Link](https://x.com/bullishbruk/status/1989800549412127147)  2025-11-15T20:59Z [----] followers, [----] engagements


"$IBRX @drpatrick @US_FDA are you listening Here is a proud American mother plea to the FDA: FDA: IM BEGGING AS A MOTHER. My sonStage [--] colon cancer. Standard of care Exhausted. Hes perfect for the Anktiva lymphopenia trialexcept ONE count [--] points too high Hes a fit devoted young dadtucking in his babies dreaming of their graduations. Cancers trying to steal him. Compassionate use. PLEASE Anktivas saving lives across cancersdont let a number orphan my grandchildren. He deserves to fight. To live. To hold them. FDASAVE MY BOY #RightToTry @FDA πŸ˜­πŸ™ @DrMakaryFDA @VPrasadMDMPH @SecKennedy"  
[X Link](https://x.com/bullishbruk/status/1989906150976893254)  2025-11-16T03:59Z [----] followers, 13.5K engagements


"$IBRX ANKTIVA Julie glad to hear Bioshield is working for you. Congrats Please keep us up to date. Thank you i suddenly realized just now: one of my major symptoms for over a year has been constant pressure around & behind my left eye. i dont feel it at all right now major victory for Anktiva. i dont know what causes it (i think maybe cryoglobulins caused by covid) but Anktiva got it i suddenly realized just now: one of my major symptoms for over a year has been constant pressure around & behind my left eye. i dont feel it at all right now major victory for Anktiva. i dont know what causes it"  
[X Link](https://x.com/bullishbruk/status/1989941870122934436)  2025-11-16T06:21Z [----] followers, [----] engagements


"Sir these 10000+ pages arent just paper theyre parents praying for one more birthday children begging for their moms laugh spouses clinging to empty beds at night. Every sheet is a soul screaming for hope. Your clinic answering each one Thats humanity at its rawest most beautiful. A Cancer Hotline + podcast YES. A thousand times YES. Let survivors voices crack through the airwaveslet ANKTIVAs 10-year miracles shatter the silence. Give families something to hold onto when scans steal their breath. Im crying and voting YES. Who else feels this in their bones πŸ™πŸ’” #ANKTIVA #CancerHotline"  
[X Link](https://x.com/bullishbruk/status/1990239822292693176)  2025-11-17T02:05Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@bullishbruk Avatar @bullishbruk Bullish

Bullish posts on X about $ibrx, dr, for all, in the the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

  • [--] Week [-------] +173%
  • [--] Month [-------] +160%
  • [--] Months [---------] +474%
  • [--] Year [---------] +12,865%

Mentions: [--] #

Mentions Line Chart

  • [--] Week [--] +15%
  • [--] Month [---] +45%
  • [--] Months [---] +386%
  • [--] Year [-----] +763%

Followers: [-----] #

Followers Line Chart

  • [--] Week [-----] +0.99%
  • [--] Month [-----] +14%
  • [--] Months [-----] +45%
  • [--] Year [-----] +61%

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 97.81% stocks 8.76% countries 5.11% celebrities 4.38% technology brands 2.19% exchanges 1.46% social networks 0.73%

Social topic influence $ibrx #8, dr 10.22%, for all 6.57%, in the 5.84%, bullish #167, alc 4.38%, just a 4.38%, end of 4.38%, matter 4.38%, elon musk 3.65%

Top accounts mentioned or mentioned by @drpatrick @drmakaryfda @immunitybio @lorimills4ca42 @alc2022 @seckennedy @nihdirectorjay @umbisam @usfda @vprasadmdmph @fda @truedat999 @adamfeuerstein @alhmd120690 @potus @newstart2024 @realdonaldtrump @drkashsarabi @megynkelly @tuckercarlson

Top assets mentioned ImmunityBio, Inc. Common Stock (IBRX) Merck & Co., Inc. (MRK) Candel Therapeutics, Inc. (CADL) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Alphabet Inc Class A (GOOGL) Duolingo, Inc. (DUOL) Ambrx Biopharma, Inc. (AMAM)

Top Social Posts

Top posts by engagements in the last [--] hours

"Benzinga 01/16/2026 11:04 $IBRX +35.70% Hedge funds don't need headlines to move they need inflection points. ImmunityBio Inc(NASDAQ:IBRX) just delivered one. ImmunityBio stock has gone vertical up nearly 96% year-to-date but the real story isn't the stock move. It's the number behind it. On Thursday ImmunityBio reported $113 million in [----] revenue marking a staggering 700% year-over-year increase the kind of acceleration that turns early positioning into visible validation. The Revenue Inflection Hedge Funds Were Positioned For The most important data point wasn't just the full-year figure."
X Link 2026-01-16T18:08Z [----] followers, [----] engagements

"So far so good BIOTECH I am in $CADL $IBRX $IOVA and $SLS.for now out on $ATOS and $CAPR"
X Link 2026-01-20T22:17Z [----] followers, [----] engagements

"Youre right the ResQ201A phase [--] trial is actively recruiting and it randomizes post-ICI progressed advanced/metastatic NSCLC patients (ECOG 0-2) to: Experimental: N-803 + (PD-1) + docetaxel Control: docetaxel monotherapy Primary endpoint: OS. Docetaxel anchors both arms as the standard second-line backbone confirming chemos role for debulking and synergy post-ICI resistance. In PD-L1-low/negative NSCLC RWE/trials show chemo + PD-1 combos often outperform IO alone (higher ORR/PFS/OS). For terminal/advanced cancer patients (short horizons): RWE is key for accelerated approvals/expansions in"
X Link 2026-02-01T18:26Z [----] followers, [---] engagements

"I believe Elon Musk with his groundbreaking advancements in technology and Dr. Patrick Soon-Shiong through his pioneering work in biology immunotherapy and cancer treatments like ANKTIVA and next-generation immune activation therapies will stand as two of the most consequential figures of our time. $IBRX https://twitter.com/i/web/status/2019397046814257177 https://twitter.com/i/web/status/2019397046814257177"
X Link 2026-02-05T13:05Z [----] followers, [----] engagements

"What truly sets Dr. Patrick Soon-Shiong and Elon Musk apart is their shared unwavering focus on advancing humanity whether through revolutionary immunotherapy and cancer breakthroughs like ANKTIVA or through transformative technologies in space AI neural interfaces and sustainable energy rather than being primarily driven by profit. That rare priority on genuine progress over pure financial gain is what makes both of them so remarkable and inspiring. https://twitter.com/i/web/status/2019412114402628078 https://twitter.com/i/web/status/2019412114402628078"
X Link 2026-02-05T14:05Z [----] followers, [---] engagements

"Well respectfully I disagree. Elons drive might look self-focused but its about scaling solutions for humanity much like Dr. Soon-Shiongs. Theyve got mutual respect public props and joint forums. Give it time; collaborations between titans like them could still happen especially with aligned goals in AI-biotech crossovers or global health. $IBRX https://twitter.com/i/web/status/2019418938111635602 https://twitter.com/i/web/status/2019418938111635602"
X Link 2026-02-05T14:32Z [----] followers, [--] engagements

"$IBRX Cup with handle https://t.co/PZWUBoHKbM Cup with handle https://t.co/PZWUBoHKbM"
X Link 2026-02-05T15:19Z [----] followers, [----] engagements

"$IBRX ANKTIVA: The pioneering and only FDA-authorized therapy specifically targeting lymphopenia reversal in cancer patientsnow demonstrating dramatic immune restoration (reversing severe lymphopenia with significant ALC increases) and extended survival across multiple solid tumor types including chemo-free combos in recurrent glioblastoma where median OS is not yet reached. The science is stacking uplymphopenia reversal isnt just a side benefit; its increasingly tied to better survival across tumor types. When the data continues to validate this the price of $IBRX will catch up big time."
X Link 2026-02-05T21:18Z [----] followers, [----] engagements

"$IBRX My own 2cents ANKTIVA doesnt rely on political backingits a legitimate breakthrough for reversing lymphopenia (low NK/T-cell counts that cripple immunity in cancer patients). As a U.S. citizen I welcome any positive nods (including from leaders) but its value is universal: restoring immune competence benefits everyone everywhere. The real barrier is Big Pharma defending their turf but thats fading. With strong data mountingFDA Expanded Access for lymphopenia in solid tumors Saudi approvals for NSCLC and bladder cancer (world-firsts for subcutaneous IL-15 in some indications) ongoing"
X Link 2026-02-06T18:17Z [----] followers, [----] engagements

"$IBRX led by Dr. Patrick Soon-Shiong pioneers Immunotherapy 2.0activating NK/T/memory cells to reverse lymphopenia defeat cancer/infections and advance longevity. Consequential and BigPharma in the making. ANKTIVA: Chemo-free durable responses. Early approvals: US/UK/EU & Saudi FDA NMIBC CIS papillary + SC metastatic NSCLC w/CPI (world-first beyond bladder). Momentum: [----] rev $113M (700% YoY growth); strong quarterly surge. Data: High 3-yr survival cystectomy avoidance long remissions. Pipeline: ResQ215B P2 launched: Chemo/lympho-free CAR-NK + ANKTIVA + ritux in indolent NHL (Waldenstrms)."
X Link 2026-02-07T22:29Z [----] followers, [----] engagements

"$IBRX @VPrasadMDMPH @DrMakaryFDA Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): Its fully approved in the US for one rare form of bladder cancer but not for the common form most patients have. So even though the same drug is already FDA-approved and https://t.co/jb46zpPbPL Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): Its fully approved in the US for one rare form of bladder cancer but not for the common form most patients have. So even though the same drug is already"
X Link 2026-02-12T17:39Z [----] followers, [----] engagements

"Dear Senator Johnson I urge you to investigate the FDAs glaring double standard in oncology approvals. In June [----] the FDA granted Mercks Keytruda a broad tissue-agnostic approval for MSI-high tumors by pooling data from five single-arm trials. Some tumor types had only N=1 or N=2 patients different doses were used and the entire approval rested on this combined dataset (see Tables [--] and [--] page [--] of the June [----] package insert). Big Pharma received accelerated approval on the weakest possible evidence. Yet innovative biotechs developing next-generation immunotherapies including IL-15"
X Link 2026-02-12T18:56Z [----] followers, [----] engagements

"@I_Am_MikeJones I felt the same way on my recent $AMAM investment had 95K @$4.2sh averaging and when it jump to $6 waited to come down and it didnt and every time it goes up I say lets wait to by the dip but dip never came and one morning I wake up and been sold with a $28 price tag"
X Link 2025-07-09T14:10Z [----] followers, [---] engagements

"Here are my top SC biotech stocks $CADL $IBRX $IOVA these three among others may be a life changing opportunity $CAPR that was huge bank Not a financial advice please do your own DD"
X Link 2025-12-08T14:24Z [----] followers, [----] engagements

"$IBRX #ANKTIVA Oncology & Immunotherapy Market Context The global oncology market is massive and growing rapidly estimates range from $250$285B in [----] projected to reach $500$670B+ by [--------] (CAGR 911.5%). The cancer immunotherapy segment (where ANKTIVA fits) is even hotter: $226$260B in [--------] forecasted to hit $443$467B by [----] (CAGR 12%). PD-1/PD-L1 inhibitors (like Keytruda) dominate with the segment at $54$62B in [----] potentially doubling to $120$138B by [----]. IMO A $200B addressable market for ANKTIVA (standalone or combo) aligns with capturing a significant slice of the exploding"
X Link 2026-01-17T01:30Z [----] followers, 10.7K engagements

"$IBRX I have to thank Adam twice first $CAPR $6 to $30 and since he posted a hit job on $IBRX now it is up 6% on a red day. @adamfeuerstein keep it coming my brother. Thank you"
X Link 2026-01-30T18:51Z [----] followers, [----] engagements

"$IBRX The gold standard of randomized controlled trials (RCTs) has always faced scrutinyits not flawless. Look at history: Vioxx sailed through RCTs got FDA approval in [----] then got yanked in [----] after real-world data exposed massive heart attack/stroke risks killing thousands. Belviq passed trials for weight loss approved 2012pulled in [----] when post-approval evidence revealed cancer links. Meridia cleared RCTs approved 1997withdrawn [----] after real-world signals showed elevated heart attacks/strokes. These arent outliers; theyre proof. Nothings perfect. Thats why we need real-world"
X Link 2026-02-01T17:59Z [----] followers, [----] engagements

"@Humanspective We are going to need ANKTIVA $IBRX"
X Link 2026-02-04T04:18Z [----] followers, [----] engagements

"How much is a cancer cure #ANKTIVA $IBRX worths to you Were you aware that a cancer cure has existed for over a decade and just approved for lung cancer in Saudi Arabia. however that same drug is highly restricted in the United States Dr. Patrick Soon-Shiong went on air with Chris Cuomo and dropped a claim that shouldve https://t.co/mLdYPSREpe Were you aware that a cancer cure has existed for over a decade and just approved for lung cancer in Saudi Arabia. however that same drug is highly restricted in the United States Dr. Patrick Soon-Shiong went on air with Chris Cuomo and dropped a claim"
X Link 2026-02-04T04:27Z [----] followers, [----] engagements

"$IBRX is it time yet ANKTIVA is a national treasure @LoriMills4CA42 $IBRX OH HE WITH THE BIG HITTERS THIS IS GETTING GOOD https://t.co/AKZZmauEZy $IBRX OH HE WITH THE BIG HITTERS THIS IS GETTING GOOD https://t.co/AKZZmauEZy"
X Link 2026-02-04T09:52Z [----] followers, [----] engagements

"$IBRX ANKTIVAs trillion-dollar potential ties directly into Dr. Patrick Soon-Shiongs bold vision: supercharging the immune systemspecifically by activating and proliferating natural killer (NK) cells T cells and memory T cellscould unlock massive $ value in longevity cancer treatment and beyond. #MAHA finally gets it https://twitter.com/i/web/status/2019527359242838078 https://twitter.com/i/web/status/2019527359242838078"
X Link 2026-02-05T21:43Z [----] followers, [----] engagements

"$IBRX demonstrated impressive relative strength during yesterdays broader market sell-off holding far better than many peers in biotech and beyond. This resilience highlights growing investor confidence in its explosive growth story (ANKTIVA ramp pipeline catalysts) while positioning it as a smart hedge against bearish macro pressuresmore buyers are likely stepping in on these dips. @DavidDin @Umbisam https://twitter.com/i/web/status/2019711556146118935 https://twitter.com/i/web/status/2019711556146118935"
X Link 2026-02-06T09:55Z [----] followers, [----] engagements

"$IBRX agree wholeheartedly $IBRX actually holding up pretty well while other popular names are getting hammered is a sign of whats to come in my opinion. Essentially we have just trapped more shorts over the last few weeks. And if we continue to hold this relative strength compared to the other popular $IBRX actually holding up pretty well while other popular names are getting hammered is a sign of whats to come in my opinion. Essentially we have just trapped more shorts over the last few weeks. And if we continue to hold this relative strength compared to the other popular"
X Link 2026-02-06T10:00Z [----] followers, [----] engagements

"$IBRX πŸš€ ANKTIVA turns Saudi Arabia into CANCER MECCA #1 SFDA accelerated approvals Jan 26: WORLD-FIRST for metastatic NSCLC (w/ checkpoint inhibitors) + BCG-unresponsive bladder CIS ( papillary) πŸ’₯ Elite med tourists flock to Riyadhs King Faisal HospNK/T-cell revival reverses lymphopenia adds YEARS to life vs. FDAs Big Pharma stall πŸ˜‚ Dr. Pat + His Excellency Bandar al-Knawys BioShield Summit: ALL tumors next While US patients are waiting. @DrMakaryFDA APPROVE LYMPOPENIA NOW Wealthy flock in stock MOONSHOTshorts lose #MAHA @DrPatrick @SenRonJohnson @bullishbruk I am from Saudi Arabia and Ive"
X Link 2026-02-06T15:46Z [----] followers, [----] engagements

"When #LadyAnktiva speaks we listen $IBRX Unleash ANKTIVA NATIONWIDE for ALL cancer Patients. No More patient by patient approvals. Cancer Patients do not have time to wait. Every oncologist should be able to give Patients to option of choice #ANKTIVA @bullishbruk Unleash ANKTIVA NATIONWIDE for ALL cancer Patients. No More patient by patient approvals. Cancer Patients do not have time to wait. Every oncologist should be able to give Patients to option of choice #ANKTIVA @bullishbruk"
X Link 2026-02-06T21:53Z [----] followers, [----] engagements

"Spot on Mohammed. Meeting Dr. Soon-Shiong and seeing Saudis real commitment sealed itlong-term transformative bets like ANKTIVAs SFDA approvals. Hes a humble visionary focused on saving lives. $IBRX isnt just a stock; its the mission to protect our loved ones. I too have a conviction. Long-term. In this together. Thank you @DrPatrick I met Dr. Patrick Soon-Shiong (@DrPatrick) in Saudi Arabia and spoke with him personally. After the conference I invested heavily in $IBRX not as a trade but as conviction. My decision was driven by two core reasons: Saudi Arabias involvement because when Saudi I"
X Link 2026-02-07T23:07Z [----] followers, [----] engagements

"Immunity has been the core focus all along. We havent even scratched the surface of what ANKTIVA can truly achieve. I firmly believe it has the potential to become one of the blockbuster drugs of our generation. $IBRX @Umbisam $IBRX A quick google search will confirm my thoughts about the potential benefit of Anktiva in Alzheimers disease. There is an association between low ALC and Disease. When IBRX is cash positive maybe they would consider a trial. Expensive it will be. $IBRX A quick google search will confirm my thoughts about the potential benefit of Anktiva in Alzheimers disease. There"
X Link 2026-02-08T01:36Z [----] followers, [----] engagements

"Hands down @grok is one of the most intelligent of all. $IBRX @MartinezAyren @bigdickee Imagine the stock market is like a big playground where people buy and sell shares of companies like trading toys. $IBRX is a company that makes medicine. Normally trading happens during "playtime" (market hours). But after closing or before opening some big kids trade in a @MartinezAyren @bigdickee Imagine the stock market is like a big playground where people buy and sell shares of companies like trading toys. $IBRX is a company that makes medicine. Normally trading happens during "playtime" (market"
X Link 2026-02-08T02:45Z [----] followers, [----] engagements

"$IBRX ANKTIVA @DrPatrick hmmmm maybe there is a connection I am just asking for a friend 🚨 BREAKING South African AIDS Vaccine Begins Human Trials. https://t.co/zRqBvZ8Og3 🚨 BREAKING South African AIDS Vaccine Begins Human Trials. https://t.co/zRqBvZ8Og3"
X Link 2026-02-08T20:30Z [----] followers, [----] engagements

"Not so evil BigPharma in the making @PhoenxLights we appreciate it $IBRX @LoriMills4CA42 Immunitybio's HR recruiting video Amazing History and the end of cancer and infectious diseases is happening now Watch and share with all @DrPatrick @ImmunityBio https://t.co/K1qsOYnbdE Immunitybio's HR recruiting video Amazing History and the end of cancer and infectious diseases is happening now Watch and share with all @DrPatrick @ImmunityBio https://t.co/K1qsOYnbdE"
X Link 2026-02-09T13:59Z [----] followers, [----] engagements

"$IBRX Riyadh 2026: Igniting Immunotherapy [---] Anktiva + NK Cell Power for Breast Lung Prostate GBM & Beyond @DrMakaryFDA The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership in Saudi and setting the launch of Anktiva with NKcell therapy- immunotherapy [---] The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership"
X Link 2026-02-09T16:48Z [----] followers, [----] engagements

"$IBRX I agree wholeheartedly @DrPatrick $IBRX lets not lose sight that the leader of this project has the tenacity of a Michael Jordan the brains of a Jonas Salk and the salesmanship of a Steve Jobs. Bet on the man $IBRX lets not lose sight that the leader of this project has the tenacity of a Michael Jordan the brains of a Jonas Salk and the salesmanship of a Steve Jobs. Bet on the man"
X Link 2026-02-10T02:57Z [----] followers, [----] engagements

"$IBRX you think so How about heading to all time high $46 @Umbisam @alc2022 $IBRX may be headed back to recent highs. https://t.co/caDij17N8H $IBRX may be headed back to recent highs. https://t.co/caDij17N8H"
X Link 2026-02-10T02:59Z [----] followers, [----] engagements

"$IBRX crew has anyone else noticed Every time @adamfeuerstein drops his latest hit piece on IBRX the stock pumps like clockwork. Coincidence Nah. The mans basically our secret bullish catalyst at this point. Keep the shade coming Adam youre doing the Lords work (for the longs). @Umbisam @alc2022 @Alhmd120690 https://twitter.com/i/web/status/2021219542148497667 https://twitter.com/i/web/status/2021219542148497667"
X Link 2026-02-10T13:47Z [----] followers, [----] engagements

"$IBRX do you believe RFK and @DrMakaryFDA are trying to sanitize the FDA IMO: The FDA isnt a health agency and never has beenits a captured corrupt institution run by Big Pharma loyalists. After the scamdemic disaster zero real prosecutions of the worst offenders proves the rot goes all the way to the top. The agency has zero remaining credibility; an FDA stamp now means suspicion not safety for millions. Until the most blatant criminals are publicly prosecuted and removed trust cannot return. The worst long-term positions must be gutted and replaced with truly independent unowned people."
X Link 2026-02-10T14:09Z [----] followers, [----] engagements

"Hell yeah @Alhmd120690 prophecy or conviction Either way youre the man $IBRX to $15+ by Feb end Ballsy call. Games in Riyadh not Wall Street: SFDA approvals for ANKTIVA in all cancer types coming regional office plans MENA momentum. Wall Streets catching up slow but Saudi ties = big unlock. Some remember others regret. Reposted saved riding. Print that $15+. πŸš€ #Anktiva #SaudiHealthcare My call: $IBRX above $15 before the end of February. This is a conviction not noise. If it doesnt happen Ill run a cash giveaway by draw for followers then Ill close this account. Remember this clearly: The"
X Link 2026-02-10T22:40Z [----] followers, [----] engagements

"$IBRX shorts trapped in hell: 135M shares short (40%+of float) Borrow pool Ghost town only 100k850k shares left vanishing quick. CTB 8.59% and climbing bleeding shorts daily just to hold. Days to cover: [--] one spark and theyre forced to chase for a week+. Gamma ramp primed: heavy calls loading $7.50$10 strikes dealer hedging = auto-buy pressure. ANKTIVA momentum + institutions stacking + retail recalling shares = borrow spigot shutting off. Exit Zero. Plan Panic. Outcome Shorts get absolutely demolished. Hold the line smash $7.50$8 on volume cascade to $15$25+. Still short $IBRX Times up."
X Link 2026-02-10T23:03Z [----] followers, [----] engagements

"@SaiseiInvesting @ParhamLevi1 @YahooFinance Kkkk RS on $7 stock never heard of it. Usually RS is for stock below $1 to gain Nasdaq listing requirement"
X Link 2026-02-11T23:04Z [----] followers, [--] engagements

"Honestly speaking In my entire investing journey $IBRX is the first stock Ive ever genuinely hoped would dipso I could scoop up more shares on the cheap. Thats how rock-solid my confidence is in this companys long-term future. @Umbisam @alc2022"
X Link 2026-02-03T15:00Z [----] followers, [----] engagements

"@StockChaser_ $IBRX At least look at it.potential is there for sure"
X Link 2026-02-08T19:50Z [----] followers, [---] engagements

"$IBRX Everyone acts like shorts are invincible phantoms lurking in the shadows. Reality check: tons of fund managers are sniffing out weakness right now ready to pile in squeeze the bears dry and walk away with billions. I am in How about you DYOR ANKTIVA @Alhmd120690 @Umbisam https://twitter.com/i/web/status/2021945387406229964 https://twitter.com/i/web/status/2021945387406229964"
X Link 2026-02-12T13:52Z [----] followers, [----] engagements

"@alc2022 So much respect for ALC"
X Link 2026-02-12T17:35Z [----] followers, [---] engagements

"@pdsandiego @JBluePolaski_ @adamfeuerstein @DrPatrick Like I have stated every time Adam starts bashing $IBRX the stock goes up Go figure"
X Link 2026-02-12T20:42Z [----] followers, [---] engagements

"@IdenixH Have you checked the recent NCCN updates Might have ANKTIVA as Prefered which insurance usually cover"
X Link 2026-02-13T16:27Z [----] followers, [--] engagements

"$IBRX God has mercy for many and a message through DR. PSS: Glioblastoma. with this life threatening disease and for which there has been little to no advances to extend progression further and sadly early death. #Bioshield #Anktiva TO THE RESCUE @DrMakaryFDA @drkashsarabi @SecKennedy @NIHDirector_Jay @VPrasadMDMPH Please sign the petition. https://chng.it/cR6X5pFCxV Glioblastoma is medicines biggest challenge. For decades and still today the treatment involves surgery followed by radiation with chemo followed by more chemo. At the end of this [--] percent of patients have a low lymphocyte"
X Link 2025-08-26T06:05Z [----] followers, [----] engagements

"$IBRX Neupogen Epogen and thanks to #Anktiva soon there is going to be a therapy for Lymphocytopenia. IMO It will be a standard and part of every chemo therapy regiment and that will be Huge GLTL"
X Link 2025-09-16T02:36Z [----] followers, [----] engagements

"$IBRX I think @DrMakaryFDA @SecKennedy @NIHDirector_Jay knows and I believe as we speak they maybe actively working on the old guard to have a paradigm shift. If you think about it this is undeniable fact and more and more people are getting exposed to it and it will be hard for the @US_FDA just to ignore it. So it is just a matter when ANKTIVA for Lymphopenia is a done deal. must be FDA approved. Working to explain to the world how and why Bioshield works. T cells and NK cells kill cancer thats irrefutable. Low NK cells and T cells means cancer grows thats irrefutable. So if there is a drug"
X Link 2025-10-23T17:05Z [----] followers, [----] engagements

"$IBRX ANKTIVA dont use radiation little to no chemo but cures and kills all type of cancer tumors but @fda refuse to approve IMO they are protecting $mrk Keytruda a $32B revenue drug. @DrMakaryFDA When you live paycheck to paycheck a high copay for an expensive drug can be devastating. We are dramatically lowering drug prices. https://t.co/bFuGmHmNl7 When you live paycheck to paycheck a high copay for an expensive drug can be devastating. We are dramatically lowering drug prices. https://t.co/bFuGmHmNl7"
X Link 2025-10-30T14:52Z [----] followers, [----] engagements

"$IBRX @drpatrick not worried about shorts has poured $3B into @ImmunityBio and the #BioShield platform just won FDA approval for BCG-unresponsive bladder cancer (the first IL-15 superagonist). This is only the opening act. Pipeline in motion: Lung Prostate Pancreas HIV Long COVID Lymphopenia (the silent killer behind millions of chemo/radiation failures) The current price noise Manipulation. But Buying Opportunity What I see A generational opportunity. GLTL πŸš€ @alc2022 Thanks. When I developed Abraxane the stock was shorted 100percent until it got approved in [----] and Nasdaq literally had to"
X Link 2025-11-13T15:49Z [----] followers, [----] engagements

"$IBRX welcome to the real problem. At least this feels like a relief it wasnt only happening to us. Prasad overruled FDA staff to reject Modernas flu vaccine application https://t.co/YR7hS86BHc via @lizzylaw Prasad overruled FDA staff to reject Modernas flu vaccine application https://t.co/YR7hS86BHc via @lizzylaw"
X Link 2026-02-12T17:15Z [----] followers, [----] engagements

"@alc2022 In due time $DUOL $1T $HIMS $1T $IBRX $1T"
X Link 2026-02-12T21:36Z [----] followers, [---] engagements

"$IBRX DD Strong conviction + patience = potential life-changing moment. My price target: $65 DYOR. Not financial advice. $IBRX Weak hands are getting flushed out. I made that mistake with my [-----] options on $ASTS. Looking back I got scared out of most of my position around $5. I sold my last [----] shares at $111.00 I will not do this with$IBRX. A short squeeze is coming. $IBRX Weak hands are getting flushed out. I made that mistake with my [-----] options on $ASTS. Looking back I got scared out of most of my position around $5. I sold my last [----] shares at $111.00 I will not do this with$IBRX."
X Link 2026-02-13T16:31Z [----] followers, [----] engagements

"$IBRX stop loss raid Shorts last Hail Mary Remember not to long a go this was trading $1.95. Do your DD buy/sell and hold Life changing opportunities doesnt come easy @Umbisam @alc2022"
X Link 2026-02-13T20:14Z [----] followers, [----] engagements

"Dear Senator Moody I urge you to call on the FDAs and demand an explanation to the glaring double standard in oncology approvals. In June [----] the FDA granted Mercks Keytruda a broad tissue-agnostic approval for MSI-high tumors by pooling data from five single-arm trials. Some tumor types had only N=1 or N=2 patients different doses were used and the entire approval rested on this combined dataset (see @DrPatrick ). Merck received accelerated approval on the weakest possible evidence. Yet innovative biotechs such as ImmunityBio developing next-generation immunotherapies including IL-15"
X Link 2026-02-14T15:57Z [----] followers, [---] engagements

"$IBRX shorts got PLAYED. They piled in heavy on insider FDA dirtbetting on papillary rejection/delays thinking ANKTIVA was dead in the water. Then Dr. Pat drops the HAMMER: Saudi FDA slams accelerated approvals for ANKTIVA in BLADDER AND NSCLC first worldwide subQ IL-15 wins revenue exploding to 700% YoY Saudi rollout + partnerships fueling cash without waiting on FDA resub. Now: 135M+ SS borrow ZERO CTB 8-9% Trapped hemorrhaging and covering means MOONSHOT FDA curveball NahSaudi curveball nuked their thesis. One more catalyst (resub data ASCO buzz earnings beat) and this EXPLODES FOMO"
X Link 2026-02-12T13:17Z [----] followers, [----] engagements

"$DUOL Just added a few more I think this might be the bottom or close to it. This year my best friends are shorts They gave me $2.23 $IBRX and $112 $DUOL @alc2022 New $DUOL VP of AI. Ex Google Director of Engineering Workspace AI. https://t.co/EBErvt2M5h New $DUOL VP of AI. Ex Google Director of Engineering Workspace AI. https://t.co/EBErvt2M5h"
X Link 2026-02-13T20:05Z [----] followers, [----] engagements

"Dear Dr. Pat I am a stock holder and do want a return on my investment however I have a far more important reason for championing ANKTIVA: it is a genuine breakthrough that can spare patients from life-altering bladder removal give hope to those with advanced lung cancer and now reach people across the Middle East thanks to you and the Kingdoms visionary regulatory leadership. https://twitter.com/i/web/status/2022751010381312205 https://twitter.com/i/web/status/2022751010381312205"
X Link 2026-02-14T19:13Z [----] followers, [--] engagements

"$IBRX Anktiva PH II studyLongCovid study for all suffering #LonCovid finally meaningful remedy is on the way #bioshield We've announced our new study called COVID-4.019-Long which further expands our clinical research efforts to assess ANKTIVAs potential beyond cancer or cancer-related diseases. Learn more about the study and its potential impact: https://t.co/2Bg0U7ScFb https://t.co/1T8gLbIlZ2 We've announced our new study called COVID-4.019-Long which further expands our clinical research efforts to assess ANKTIVAs potential beyond cancer or cancer-related diseases. Learn more about the"
X Link 2025-08-19T13:52Z [----] followers, [----] engagements

"$IBRX if this news was any other biotech company the PPS would have jumped 600% just to show you how BigPharma is scared to death of #bioshield #Anktiva and keep shorting it no matter what. They must have one person at all time glued to the desk and monitoring the stock movements @drpatrick @DavidDin @drkashsarabi Weve announced that our initial data shows 100% disease control in [--] out of [--] patients with recurrent glioblastoma after being treated with our ANKTIVA NK cell therapy plus the Optune Gio device. Read more: https://t.co/Myk1ehjs7e https://t.co/nlcQMoCrvi Weve announced that our"
X Link 2025-08-26T14:31Z [----] followers, [----] engagements

"$IBRX @ImmunityBio FDA please approve #bioshield and let us get rid of #LongCovid show your support Please sign the petition https://chng.it/cR6X5pFCxV https://chng.it/cR6X5pFCxV"
X Link 2025-08-30T17:13Z [----] followers, [----] engagements

"$IBRX #Bioshield #Anktiva by @ImmunityBio getting rid of Cancer Tumors and LongCovid. @DrMakaryFDA Another inspiring story on the power of ANKTIVA Bioshield in driving NK cells even across the blood brain barrier to the brain tumor. Recurrent glioblastoma trial now open https://t.co/IA7l3lUvGi https://t.co/TrrmgEVcFO Another inspiring story on the power of ANKTIVA Bioshield in driving NK cells even across the blood brain barrier to the brain tumor. Recurrent glioblastoma trial now open https://t.co/IA7l3lUvGi https://t.co/TrrmgEVcFO"
X Link 2025-09-04T15:11Z [----] followers, [----] engagements

"Cute insultechoes are loudest in empty spaces. Yes I read Katherine Ebans May [----] Vanity Fair piece. Its a detailed six-month investigation interviewing nine former colleagues who dispute key parts of Calley Means backstory: his claimed direct role lobbying for Coke/Pharma clients staffing high-level meetings and being an insider whistleblower. They say he was a junior consultant not central to those accounts and his narrative got amplified for influence. His ex-mentor Steve Schmidt calls him not a whistleblower but an opportunist. Means responded by standing by his statements and dismissing"
X Link 2025-12-31T04:51Z [----] followers, [--] engagements

"@OccupyDemocrats Well I dont know if he owns the said equities but if he does this just proves that he is a smart businessman and definitely he doesnt mix business with politics"
X Link 2023-04-27T01:19Z [----] followers, 60.2K engagements

"@OccupyDemocrats At the end of the day it is all about the money. reputation my foot"
X Link 2023-05-05T17:23Z [----] followers, 43K engagements

"@Spriter99880 I have been saying war is not a comedy show and it is not a joke but Zelenskyy thought otherwise"
X Link 2023-05-07T16:30Z [----] followers, 16.1K engagements

"@nexta_tv @sharkbiotech If this continues I might volunteer to go and fight side by side with IDF I am not even a Jew"
X Link 2023-10-29T18:58Z [----] followers, [----] engagements

"#bioshield # ANKTIVA of @ImmunityBio $IBRX @drpatrick the great scientist go where no scientist has gone ever before The beginning of the end of Evil BigPharma. Dr. Pat THANK YOU I wil draft an X article today to discuss this finding that every [--] percent drop in NK and T cells results in [--] percent increased risk of death in lung cancer Preventable today with Bioshield since we activate NK cells with a subcutaneous jab. Your body is the factory. https://t.co/HLiCrXKkAc I wil draft an X article today to discuss this finding that every [--] percent drop in NK and T cells results in [--] percent"
X Link 2025-06-07T18:01Z [----] followers, [----] engagements

"A must read I call #Bioshield #Thanktiva as a #Cancer irradiator. Thank you @drpatrick $IBRX https://t.co/ATMycjbTqk https://t.co/ATMycjbTqk"
X Link 2025-06-14T20:16Z [----] followers, [----] engagements

"$IBRX #Bioshield #Anktiva has been approved in UK. Great news for United Kingdom MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer The Medicines and Healthcare products Regulatory Agency (MHRA) has today [--] July [----] approved nogapendekin alfa inbakicept (Anktiva) for adu https://t.co/YqVc33qMj6 MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer The Medicines and Healthcare products Regulatory Agency (MHRA) has today [--] July [----] approved nogapendekin alfa inbakicept (Anktiva) for"
X Link 2025-07-04T15:21Z [----] followers, 136K engagements

"And guess what multiplies these Killer cells A drug just got approved last year called #ANKTIVA #Bioshield Lymphocytes- stimulator by @ImmunityBio @drpatrick spent the last [--] years of his life and $3B of his hard earned money invented it. Instead of only for bladder cancer Hope @fda approve it for all cancer indications soon. Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. πŸ”¬ Alex Ritter / RitterLab https://t.co/sQZ7Som3V9 Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. πŸ”¬ Alex Ritter / RitterLab"
X Link 2025-07-09T01:45Z [----] followers, 85.3K engagements

"$IBRX bioshield (Thanktiva) the best immune stimulant to clear LongCovid it is just a no brainer. As far as safety and CR ANKTIVA has been showing strong CR and been the safest what is the @fda waiting for Need to clear and approve for all cancer tumor type and most importantly as a first line. @DrMakaryFDA please stop the old guard shenanigans protecting $MRK Keytruda and approve ANKTIVA for all tumors type now. @drpatrick @SecKennedy @NIHDirector_Jay One of the most difficult tumors to treat.glioblastoma. We will soon open a trial with @DrSimonKhagi for patients with newly diagnosed brain"
X Link 2025-07-20T15:45Z [----] followers, [----] engagements

"We now know mRNA vaccine is not 100% effective against COVID may even be harmful to some but according to @drpatrick (world renowned scientist surgeon) #bioshield #ANKTIVA by @ImmunityBio $IBRX is effective clearing out the spike protein (Covid/vaccine) from our body and has the ability to stimulate and strength our own God given immunity against other illness including cancer with more than [--] years safety data available. Isnt it time to authorize and clear #LongCovid @SecKennedy @DrMakaryFDA @NIHDirector_Jay @megynkelly @TuckerCarlson Dr. Patrick Soon-Shiong a pioneering surgeon and"
X Link 2025-08-09T15:09Z [----] followers, [----] engagements

"$IBRX I am so Happy for @GretchMick she looks amazingly healthy and happy. Congrats I believe you are on your way to be a Healthy and vibrant woman. cancer has been beaten πŸ‘ŠπŸΌBioshield Complete. 🚫 colon cancer 🚫 #cancer #coloncancer #chemo #capecitabine #bioshield #MAHA @ImmunityBio $IBRX https://t.co/yvmHfHJ1F8 πŸ‘ŠπŸΌBioshield Complete. 🚫 colon cancer 🚫 #cancer #coloncancer #chemo #capecitabine #bioshield #MAHA @ImmunityBio $IBRX https://t.co/yvmHfHJ1F8"
X Link 2025-08-12T20:30Z [----] followers, [----] engagements

"$IBRX now you all know why BigPharma is fighting Bioshield to keep it out of the market. Cancer cure without chemo and radiation it is just a matter of time @ImmunityBio ANKTIVA is making waves. For now BigPharma might win the battle but eventually $IBRX will win the war @drpatrick @DrMakaryFDA $IBRX ImmunityBio sees successful outcomes in Non-Hodgkin Waldenstrom Lymphoma patients using CD19 CAR-NK immunotherapy without chemotherapy. More Info: https://t.co/8dCoyPjezS $XBI $IBB $XPH $PPH https://t.co/vtch0GK1Mi $IBRX ImmunityBio sees successful outcomes in Non-Hodgkin Waldenstrom Lymphoma"
X Link 2025-08-13T13:15Z [----] followers, [----] engagements

"$IBRX with more good news BigPharma is doubling down and shorting IBRX to death. now 85% 80M+ shorted shares. Sooner or later they have to cover and meantime we are accumulating. The time is on our side. Patience PT $65"
X Link 2025-08-13T13:33Z [----] followers, [----] engagements

"$IBRX the power of #Bioshield all its waiting for is a complete paradigm shift and the beginning of the end of cancer and let us not forget that the current president is @realDonaldTrump this will never happened with any other president. Big Thank you to @POTUS @DrMakaryFDA @SecKennedy The power of NK cells. After a single cycle of NK cells targeting the tumor the patient with a rare lymphoma (WM) [---] percent of bone marrow infiltrated ( left PET scan) achieved a COMPLETE RESPONSE ( right scan). Had failed all other therapy. The power of the BIOSHIELD platform. https://t.co/a6ZWSoWzJX The"
X Link 2025-08-13T15:46Z [----] followers, [----] engagements

"$IBRX Longs this is the kind of tweet that makes you be proud of your investment in the company. But we need to get #Bioshield approved and so many can be saved. While BigPharmas get keeper @US_FDA playing games we are running out of time. Please sign the petition. https://chng.it/cR6X5pFCxV Patient would like me to share this wonderful response to the Bioshield. from not being able to speak clearly because of tumor to now singing his song in our clinic. What a blessing. https://t.co/fLrnBT1HYC https://chng.it/cR6X5pFCxV Patient would like me to share this wonderful response to the Bioshield."
X Link 2025-08-23T20:57Z [----] followers, [----] engagements

"$IBRX #Bioshield couldnt repost it enough The message needs to be out repeatedly so everyone can experience a paradigm shift. We need it Huge Thanks to @newstart_2024 he is doing his part. Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's a devastating paradox at the heart of modern cancer care. As articulated by Dr. Patrick Soon-Shiong we are systematically poisoning the body's single most powerful https://t.co/DzjEcfAZGF Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's"
X Link 2025-08-24T17:04Z [----] followers, [----] engagements

"$IBRX GretchMick: because of #Anktiva #Bioshield I believe I am cancer free GretchMick Congrats So happy for you @US_FDA @drpatrick @DrMakaryFDA @SecKennedy @NIHDirector_Jay @POTUS @elonmusk Post Bioshield Test Results #cancersurveillance #cancer #coloncancer #chemo #bioshield $IBRX @ImmunityBio @CCAlliance https://t.co/LpEXPqTswt Post Bioshield Test Results #cancersurveillance #cancer #coloncancer #chemo #bioshield $IBRX @ImmunityBio @CCAlliance https://t.co/LpEXPqTswt"
X Link 2025-08-25T20:06Z [----] followers, [----] engagements

"$IBRX chemo and radiation therapy to kill cancer tumor is like "cut off your nose to spite your face" because it will wipe out your immune system. A new therapy #bioshield #Anktiva by @ImmunityBio with little or no chemo kills all type of Cancer tumors and clears LongCovid just by stimulating and energizing your own God given immune system"
X Link 2025-08-26T06:35Z [----] followers, [----] engagements

"$IBRX Alan congratulations We appreciate you sharing your experience with #Bioshield #Anktiva success story. Thank you @drpatrick @DrMakaryFDA @SecKennedy @bullishbruk @US_FDA @drpatrick @DrMakaryFDA @SecKennedy @NIHDirector_Jay @POTUS @elonmusk Thank you for sharing I am another successful story as N=1 prostate cancer patient and complete response (cancer free) to BioShield combined with localized radiation. My story coming up on video soon. CONGRATULATIONS @bullishbruk @US_FDA @drpatrick @DrMakaryFDA @SecKennedy @NIHDirector_Jay @POTUS @elonmusk Thank you for sharing I am another successful"
X Link 2025-08-26T13:18Z [----] followers, [----] engagements

"$IBRX is @fda waiting till most Glioblastoma patients are dead Let us look ANKTIVA is clear for safety and approved with 10+ years worth of safety data. Why wait on terminal disease such cancer especially Glioblastoma @DrMakaryFDA needs to expedite the approval as soon as possible. Many needs Bioshield now Weve announced that our initial data shows 100% disease control in [--] out of [--] patients with recurrent glioblastoma after being treated with our ANKTIVA NK cell therapy plus the Optune Gio device. Read more: https://t.co/Myk1ehjs7e https://t.co/nlcQMoCrvi Weve announced that our initial data"
X Link 2025-08-26T13:41Z [----] followers, [----] engagements

"$IBRX the pix says a lot If this is not a cure I dont know what it is. #Bioshield #Anktiva @ImmunityBio Initial data shows [--] patients with near Complete Response & 100% disease control in first [--] patients. When the immune system is protected CR in tumors difficult to treat in recurrent GBM is possible. GBM trial open at https://t.co/wwLWOlBYtC Data for lung cancer next #WCLC25 https://t.co/wdCDGQ1zhf Initial data shows [--] patients with near Complete Response & 100% disease control in first [--] patients. When the immune system is protected CR in tumors difficult to treat in recurrent GBM is"
X Link 2025-08-26T18:22Z [----] followers, [----] engagements

"$IBRX a prophecy #ANKTIVA is going to be huge. you know when you are in the know thanks ANKTIVA. Remember that word/therapy. ANKTIVA. Remember that word/therapy"
X Link 2025-08-28T17:26Z [----] followers, [----] engagements

"$IBRX "BioShield" (ANKTIVA) @drpatrick The BioShield is not a vaccine in the traditional sense but rather an immunotherapy designed to restore and activate the patient's own immune system to fight cancer and potentially other infections like Long COVID. It works by stimulating Natural Killer (NK) and T cells which are critical for a patient's immune response. IT CLEARS LongCovid @SecKennedy @peterthiel @NIHDirector_Jay @DrMakaryFDA"
X Link 2025-08-30T13:50Z [----] followers, [----] engagements

"$IBRX if you are a cancer patient or suffering from LongCovid you should read this and ask questions. It is your life or death @US_FDA @DrMakaryFDA Dr. P.S.S: Next week we will share our data in [--] patients with lung cancer who failed chemo and some who failed both chemo and radiation.But why are we waiting to catch patients once they already in a deep hole Why not protect their cells from the outset @VPrasadMDMPH @POTUS @SecKennedy @NIHDirector_Jay Next week we will share our data in [--] patients with lung cancer who failed chemo and some who failed both chemo and radiation and all [--] who"
X Link 2025-08-31T03:40Z [----] followers, [----] engagements

"$IBRX it is time for @drpatrick to come out and publicly expose Francis Collins (then NIH director) and Tony Fauci what both did to exclude the only therapy that cleared COVID virus form our body #Bioshield ANKTIVA by @ImmunityBio from warp speed in [----]. @RealAlexJones @newstart_2024 @realDonaldTrump @RWMaloneMD"
X Link 2025-09-01T18:35Z [----] followers, [----] engagements

"$IBRX #Bioshield This great news is a Labor Day gift not only for Lung-cancer patients but a hope for all type of cancer patients including people suffering from LongCovid. Long live Dr. PSS. Thank you @adamfeuerstein @drkashsarabi @DrMakaryFDA @RWMaloneMD NCI supported PRAGMATICA lung trial failed but established real world survival after chemo of [--] mo. Our Bioshield trial in lung patients who progressed show when NK & T cells are activated survival is doubled & some patients live 4+ yrs in late stage of cancer Coming this week https://t.co/O1ysbaJyV5 NCI supported PRAGMATICA lung trial"
X Link 2025-09-01T20:08Z [----] followers, [----] engagements

"$IBRX there is only one remedy to clear COVID and mRNA vaccine from our body that is #bioshield #ANKTIVA by @drpatrick BARDA need to fund @ImmunityBio NOW"
X Link 2025-09-01T21:36Z [----] followers, [----] engagements

"$IBRX David Excellent The companys PR department needs to hire you. Thank you #Anktiva #Bioshield NEW CANCER DRUG ANKTIVA STRONGLY INCREASES OVERALL SURVIVAL OF TERMINAL LUNG CANCER PATIENTS Data from a completed clinical trial shows that lung cancer patients who have failed all FDA approved optionschemo radiation and checkpoint inhibitorsand have no more treatments https://t.co/WeFtS5L5jE NEW CANCER DRUG ANKTIVA STRONGLY INCREASES OVERALL SURVIVAL OF TERMINAL LUNG CANCER PATIENTS Data from a completed clinical trial shows that lung cancer patients who have failed all FDA approved"
X Link 2025-09-06T12:10Z [----] followers, [----] engagements

"$IBRX Lung Cancer patients survival tripled (7months vs 21Months) with #Bioshield #Anktiva a $50B+ company in the making Weve announced new paradigm-changing findings from the Phase [--] QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural killer and T cells) in patients with checkpoint inhibitor-resistant advanced non-small cell lung cancer https://t.co/aTxCJgqQnZ Weve announced new paradigm-changing findings from the Phase [--] QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural"
X Link 2025-09-08T13:31Z [----] followers, [----] engagements

"$IBRX we had one of the best news of LunCancer triples survival vs current therapy and we go down $2.35 like the drug killed somebody it is just obvious IMO @drpatrick should hire a PI and find out who is manipulating the stock IMO one of the BigPharma like $MRK maybe doing it"
X Link 2025-09-08T13:53Z [----] followers, [----] engagements

"$IBRX #bioshield #Anktiva paradigm shifts slowly but surely Oncologists from Ohio State at WCLC25 demonstrate that absolute lymphocyte count (ALC) matters. When lymphocytes are recovered the survival rate is doubled to [-----] months The cancer world is waking up to the concept of ALC and how chemo-radiation destroys our NK and T cells. https://t.co/g6FJTvwLpI Oncologists from Ohio State at WCLC25 demonstrate that absolute lymphocyte count (ALC) matters. When lymphocytes are recovered the survival rate is doubled to [-----] months The cancer world is waking up to the concept of ALC and how"
X Link 2025-09-08T21:26Z [----] followers, [----] engagements

"$IBRX so happy to hear so far @GretchMick is cancer free #bioshield #anktiva @DrMakaryFDA @POTUS @SecKennedy @NIHDirector_Jay @drpatrick CT Scan Results #coloncancer #cancer @ImmunityBio #bioshield https://t.co/daqrsIAyVH CT Scan Results #coloncancer #cancer @ImmunityBio #bioshield https://t.co/daqrsIAyVH"
X Link 2025-09-08T23:16Z [----] followers, [----] engagements

"$IBRX Thanks to @drpatrick promoting #Bioshield #Anktiva has been successful and soon many patients will request it and Doctors will have to prescribe it for all cancer tumor type including LongCovid. A $50B+ MC company in the making I think most people miss one thing about $IBRX ANKTIVA (N-803) isnt just a bladder cancer drug its an immune system drug so the potential is huge to target a multitude of cancers. A lot of patients and doctors start to understand it that's why ImmunityBio receives so many I think most people miss one thing about $IBRX ANKTIVA (N-803) isnt just a bladder cancer"
X Link 2025-09-11T13:31Z [----] followers, [----] engagements

"$IBRX unlimited opportunity $2.4B MC is a joke. I say $24B+MC for starter and in due time this company should be a $100B+ MC. Invest wisely do your DD. The future is here. Cell therapy especially CAR-NK therapy is the next era of cancer care. Especially when you combine cell therapy w cytokines such as ANKTIVA. Amassing cancer killer cells @ImmunityBio Waldenstrom trial open at https://t.co/wwLWOlBYtC https://t.co/ReBX8DHoje The future is here. Cell therapy especially CAR-NK therapy is the next era of cancer care. Especially when you combine cell therapy w cytokines such as ANKTIVA. Amassing"
X Link 2025-09-15T13:48Z [----] followers, [----] engagements

"$IBRX #Bioshield is the one that cleared both COVId and mRNA vaccine spike protein. FDA approvals needed @SecKennedy @DrMakaryFDA RIP Charlie Kirk. Renowned surgeon & scientist Dr. Patrick Soon-Shiong delivered a chilling warning to Charlie Kirk and his audience: The world was facing a global pandemic of "turbo cancers" in young people. The anecdotal evidence had become a terrifying medical reality. Cancer https://t.co/pBuP7hFml0 RIP Charlie Kirk. Renowned surgeon & scientist Dr. Patrick Soon-Shiong delivered a chilling warning to Charlie Kirk and his audience: The world was facing a global"
X Link 2025-09-17T11:35Z [----] followers, [----] engagements

"$IBRX #bioshield international exposure Inspiring to see patients receiving cellular therapies here in Riyadh. Looking forward to seeing future possibilities with our #BioShield at King Faisal Specialist Hospital & Research Centre #SaudiUSForum2025 @MISA @Saudi_FDA https://t.co/8iYTlwPzIe Inspiring to see patients receiving cellular therapies here in Riyadh. Looking forward to seeing future possibilities with our #BioShield at King Faisal Specialist Hospital & Research Centre #SaudiUSForum2025 @MISA @Saudi_FDA https://t.co/8iYTlwPzIe"
X Link 2025-09-17T12:24Z [----] followers, [----] engagements

"$IBRX @NIHDirector_Jay @DrJBhattacharya searching for #LongCovid therapy how about speaking to @drpatrick #Bioshield is available and it will get rid of both Covid and mRNA spike proteins .@NIHDirector_Jay: A Long COVID patient came up to me and said Im desperate please help and I assured her that were going to find an answer. https://t.co/d5X4dCleDO .@NIHDirector_Jay: A Long COVID patient came up to me and said Im desperate please help and I assured her that were going to find an answer. https://t.co/d5X4dCleDO"
X Link 2025-09-18T20:50Z [----] followers, [----] engagements

"$IBRX paradigm shift is taking place it just a matter of time #bioshield will be approved by @fda to treat Lymphopenia and every time people gets a chemo/radiation treatments they have to take ANKTIVA to boost their NK cells A landmark publication at ASCO [----] has finally acknowledged the unthinkable: radiation therapy can induce metastasis spreading the cancer it was meant to treat. This is the seismic shift in oncology revealed by Dr. Patrick Soon-Shiong. The largest gathering of global https://t.co/A5W7WzAGx0 A landmark publication at ASCO [----] has finally acknowledged the unthinkable:"
X Link 2025-10-07T01:00Z [----] followers, [----] engagements

"Well how about approving Bioshield (ANKTIVA) for Lymphopenia I am sure you know @drpatrick talk to him Harnessing AI to make America healthy again By Marty Makary Jim O'Neill Imagine what would happen if the government put Boeing in charge of airline safety or if fast-food chains set national nutrition standards. Such an irony took place when then-President Joe Biden allowed Harnessing AI to make America healthy again By Marty Makary Jim O'Neill Imagine what would happen if the government put Boeing in charge of airline safety or if fast-food chains set national nutrition standards. Such an"
X Link 2025-10-09T17:09Z [----] followers, [----] engagements

"$IBRX Queen Megyn absolutely His legacy depending on it and definitely the Nobel Prize will be in the bag This should be available for the rest of the country @drpatrick on why he believes Trump can implement his plan to prevent and cure cancer. Watch and download: https://t.co/F96HgI7HIW https://t.co/QXv4nBM14A This should be available for the rest of the country @drpatrick on why he believes Trump can implement his plan to prevent and cure cancer. Watch and download: https://t.co/F96HgI7HIW https://t.co/QXv4nBM14A"
X Link 2025-10-09T21:34Z [----] followers, [----] engagements

"It amazes me that here we have #bioshield ANKTIVA already available doing almost the same thing but people ignoring it and looking the other way if #bioshield was presented by BigPharma instead of @drpatrick everyone including @ScottAdamsSays would have called it a breakthrough and a miracle of the century. @newstart_2024 @megynkelly @TuckerCarlson @Rainmaker1973 @seanspicer Next-gen vaccine prevents up to 88% of multiple aggressive cancers Paul McClure New Atlas A next-generation cancer vaccine has shown stunning results in mice preventing up to 88% of aggressive and difficult-to-treat"
X Link 2025-10-11T16:40Z [----] followers, [----] engagements

"Once again @DrMakaryFDA @SecKennedy @DrJBhattacharya @realDonaldTrump #CancerCure Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with long-term survival regardless of tumor types. Current https://t.co/Lczvpeqc6z Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with"
X Link 2025-10-13T19:28Z [----] followers, [----] engagements

"#Bioshield #Anktiva a #cancercure that @US_FDA holding hostage @RealAlexJones @newstart_2024 @Rainmaker1973 @VigilantFox @megynkelly @seanspicer @TuckerCarlson Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with long-term survival regardless of tumor types. Current https://t.co/Lczvpeqc6z Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating"
X Link 2025-10-13T19:32Z [----] followers, [----] engagements

"Cancer therapy breakthrough It is not mRNA Chemo nor Radiation @drpatrick Bioshield stimulate and boosts your own God given immune system fight and get rid of every types of cancer. A Cancer Breakthrough That Changes Everything In a stunning medical advance Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancersincluding brain pancreatic and head & neck tumorsafter all other treatments https://t.co/0njJPLM0yb A Cancer Breakthrough That Changes Everything In a stunning medical advance Dr. Patrick Soon-Shiong reveals a platform"
X Link 2025-10-14T23:46Z [----] followers, [----] engagements

"$IBRX Proven in clinics: BCG-unresponsive NMIBC ANKTIVA + BCG hit 71% complete response rate (vs. 0% historical). Now expanding: Phase [--] trials show lymphopenia reversal in lung/prostate cancers improving PFS by 30-40%. FDA Expanded Access in June '25. #NMIBC #BladderCancer"
X Link 2025-10-15T10:02Z [----] followers, [----] engagements

"Let that sink in It's wild: A patient will bravely endure chemo's harsh effects but the suggestion to cut sugar eat clean and detox is treated as radical unscientific nonsense. The conditioning is real. It's wild: A patient will bravely endure chemo's harsh effects but the suggestion to cut sugar eat clean and detox is treated as radical unscientific nonsense. The conditioning is real"
X Link 2025-10-15T11:24Z [----] followers, [----] engagements

"$IBRX meeting at EMA (fda for EU) today is the last day of the monthly [--] days long meeting and ANKTIVA is on the agenda"
X Link 2025-10-16T14:04Z [----] followers, [----] engagements

"$IBRX wouldnt be nice if we can get IVM and Bioshield combined as a cancer cure regiment approved and available worldwide Other IVMs anti-cancer mechanisms of action: Inhibits tumor growth/proliferation Inhibits tumor initiation/progression Regulates tumor micro-environment Causes cancer cell mitochondrial dysfunction Stops cancer cell migration invasion & metastasis https://t.co/ZBGkMolN2e Other IVMs anti-cancer mechanisms of action: Inhibits tumor growth/proliferation Inhibits tumor initiation/progression Regulates tumor micro-environment Causes cancer cell mitochondrial dysfunction Stops"
X Link 2025-10-16T17:17Z [----] followers, [----] engagements

"$IBRX #BIoshield a road map to a meaningful cancer cure without the usual chemo/radiations nasty and debilitating side effects After [--] years of unraveling cancer's diabolical nature Dr. Patrick Soon-Shiong reveals a paradigm shift: We've been fighting cancer all wrong. The old war of attrition with high-dose chemo and radiation is failing. Cancer is a clever adaptive entity that hides from our immune https://t.co/enGT037VHa After [--] years of unraveling cancer's diabolical nature Dr. Patrick Soon-Shiong reveals a paradigm shift: We've been fighting cancer all wrong. The old war of attrition"
X Link 2025-10-16T21:34Z [----] followers, [----] engagements

"I have a feeling #bioshield ANKTIVA for LongCovid or Lymphopenia is going to be on the next list FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability domestic production or meeting an unmet public health need. https://t.co/oUuEsAnBQ2 FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability domestic production or meeting an unmet public health need. https://t.co/oUuEsAnBQ2"
X Link 2025-10-16T22:46Z [----] followers, [----] engagements

"$IBRX ANKTIVA TO HE RESCUE A peer-reviewed Italian study reveals a shocking spike in cancer rates following COVID-19 vaccination. Hazard Ratios at 6-month follow-up: ➠ Breast Cancer: +54% ➠ Bladder Cancer: +62% ➠ Colorectal Cancer: +34% As noted by Dr. John Campbell this is the critical data the https://t.co/vuvVCHNQ8C A peer-reviewed Italian study reveals a shocking spike in cancer rates following COVID-19 vaccination. Hazard Ratios at 6-month follow-up: ➠ Breast Cancer: +54% ➠ Bladder Cancer: +62% ➠ Colorectal Cancer: +34% As noted by Dr. John Campbell this is the critical data the"
X Link 2025-10-23T21:40Z [----] followers, [----] engagements

"$IBRX $IBRX is the company that could save the world 🧡 https://t.co/uvWSujlLOM $IBRX is the company that could save the world 🧡 https://t.co/uvWSujlLOM"
X Link 2025-10-24T18:17Z [----] followers, 30.2K engagements

"$IBRX Lymphopenia is going to have a therapy and it is going to be none other than BIOSHIELD ANKTIVA. World wide market is huge $500B+ and so far you only have ANKTIVA. PT $65 Wow. Finally the dots are connecting Great thread. My greatest fear seems to be playing out .Covid has immunosuppressed millions of lives and tumors ( even rare cancers) that were in remission are now re-occurring. Lymphocytes matter. ALC matters. I will begin a thread again Wow. Finally the dots are connecting Great thread. My greatest fear seems to be playing out .Covid has immunosuppressed millions of lives and"
X Link 2025-10-25T16:05Z [----] followers, [----] engagements

"$IBRX @RobSchneider Dr. Patrick Soon-Shiong isnt Big Pharmahes fighting it. [--] yrs & billions later his ANKTIVA (the Cancer BioShield) got FDA approval but ONLY for BCG-unresponsive bladder cancer after chemo/radiation fails. It reverses lymphopenia boosts NK/T cells and shows promise across solid tumors + Long COVID trials. Yet broader use is blocked. Oncology market $200B+. Coincidence @ImmunityBio #ANKTIVA #CancerBioShield"
X Link 2025-10-29T01:39Z [----] followers, [----] engagements

"Urgent Call to Action: Free #Bioshield #ANKTIVA from FDA Delays and Save Cancer Patients Lives. Dear @CalleyPoche and @DrMakaryFDA @US_FDA Leadership Every day that #ANKTIVA remains trapped in regulatory limbo is another day cancer patients are denied a proven life-extending therapy. #Bioshield the innovative immunotherapy behind ANKTIVA has already demonstrated remarkable efficacy in clinical trialsdelivering complete remissions in high-risk BCG-unresponsive bladder cancer patients where no other options exist. This isnt experimental hope; its validated science backed by peer-reviewed data"
X Link 2025-11-01T16:20Z [----] followers, [----] engagements

"$IBRX @alc2022 NK cells could extend your life (NK) Natural Killer Cells Matte ANKTIVA will be the #1 go to therapy 🧬 NK CELLS MATTER Cientficos revelan que pacientes con bajos niveles de linfocitos (linfopenia) tienen menor supervivencia sin importar el tipo de cncer. La nueva terapia Anktiva activa las clulas NK y T revirtiendo esta deficiencia y fortaleciendo el sistema inmune - FDA https://t.co/an8FKso7EM 🧬 NK CELLS MATTER Cientficos revelan que pacientes con bajos niveles de linfocitos (linfopenia) tienen menor supervivencia sin importar el tipo de cncer. La nueva terapia Anktiva"
X Link 2025-11-01T19:10Z [----] followers, [----] engagements

"$IBRX DR.Pat Sir that is a great news We need @ScottAdamsSays to stay with us a bit longer His unique wisdom is irreplaceable. Scott we can add Anktiva to Pluvicto and have exciting data in Prostate cancer. Please reach out to the clinic @cssifm and we will help you. Raising your NK and T cells can change the course. We have to apply to FDA one patient at a time. But will get that done. Details Scott we can add Anktiva to Pluvicto and have exciting data in Prostate cancer. Please reach out to the clinic @cssifm and we will help you. Raising your NK and T cells can change the course. We have"
X Link 2025-11-02T20:38Z [----] followers, [----] engagements

"$IBRX Keytruda FDA approvals from single-arm trials but not ANKTIVA why @DrMakaryFDA is it fair Heres the rundown [--]. HNSCC Aug [--] [----] [--]. cHL (R/R adults): May [--] [----] [--]. cHL (peds [--] pr): Oct [--] [----] [--]. PMBCL Jun [--] [----] [--]. Urothelial May [--] [----] [--]. NMIBC (BCG-unresp w/CIS): Jan [--] [----] [--]. MSI-H/dMMR May [--] [----] [--]. HCC (HBV): Nov [--] [----] [--]. MCC Dec [--] [----] [--]. cSCC Jun [--] [----] [--]. TMB-H solids Jun [--] [----] [--]. Endometrial (adv MSI-H/dMMR post-tx): Jun [--] [----] [--]. RCC non-clear cell Aug [----] (est.) [--]. Urothelial (w/enfortumab vedotin plat-ineligible): Dec [----] Many acceleratedconfirmatory trials"
X Link 2025-11-05T08:26Z [----] followers, [----] engagements

"$IBRX Pray for Scott Adams He started his Pluvicto and Thanks to @drpatrick apparently he is going to do Bioshield as well. Smart Man Scott Adams medical update Yesterday he completed the first of six rounds of Pluvicto which will take several months and has a one in three chance of working. In addition to this he will be doing BioShield. Please continue to pray for Scott https://t.co/cBB4AiQc5s Scott Adams medical update Yesterday he completed the first of six rounds of Pluvicto which will take several months and has a one in three chance of working. In addition to this he will be doing"
X Link 2025-11-05T23:17Z [----] followers, [----] engagements

"@jayplemons I am very happy he started his treatment and extra excited he started ANKTIVA Bioshield. I have a feeling he is going to beat it"
X Link 2025-11-05T23:39Z [----] followers, [----] engagements

"$IBRX ANKTIVA: FDA-approved for bladder cancer reverses lymphopenia in 80% saves lives via Expanded Access. Yet full approval to fix cancers #1 killer (immune collapse) is BLOCKED. Same FDA that crushed $QURE. Small biotech = death by bureaucracy. @WSJopinion RUN THIS: FDAs War on Wonder Drugs Patients dying. UK approved. Trump/Kennedy HHSdrain the swamp NOW. #ANKTIVA #MAHA"
X Link 2025-11-07T09:42Z [----] followers, [----] engagements

"$IBRX ANKTIVA: reverses lymphopenia in 80% saves lives via Expanded Access. Yet full approval to fix cancers #1 killer (immune collapse) is BLOCKED. death by bureaucracy. @WSJopinion RUN THIS: FDAs War on Wonder Drugs Patients are dying. The FDA is making news for all of the wrong reasons and the dysfunction could have life and death consequences for patients. https://t.co/aHDBYUMbam The FDA is making news for all of the wrong reasons and the dysfunction could have life and death consequences for patients. https://t.co/aHDBYUMbam"
X Link 2025-11-07T10:21Z [----] followers, [----] engagements

"Massive undeniable catalyst in biotechnology: a true cancer cure that skips chemo entirely IMO $IBRX is about to pull the exact same move as $QMMM did from $2.08 $303. The question isnt if its when. Patience pays πŸš€πŸ’‰"
X Link 2025-11-08T14:48Z [----] followers, [----] engagements

"Im long [--] stocks but rarely talk about any except $IBRX. Thanks to @drpatrick I know what ANKTIVA is truly capable of. If my mom were still here it couldve saved her. Nothing would make me happier than seeing ANKTIVA fully approved for Lymphopenia and millions of cancer patients finally getting the lifeline they deserve. πŸš€πŸ™ #ANKTIVA"
X Link 2025-11-08T19:29Z [----] followers, [----] engagements

"$IBRX @adamfeuerstein Please take a moment to read Dr. PSSs response to Marys inquiry. Youll notice a clear difference: Dr. PSS provides a detailed evidence-based answer genuinely aimed at advancing scientific understanding and patient care while your earlier gotcha question seemed more focused on controversy than progress. Constructive dialogue moves the field forward. Hope this is helpful. #Anktiva #Bioshield @alc2022 Thanks for the thoughtful questions Mary. Youre absolutely rightALC is a powerful prognostic marker and weve now demonstrated across [--] tumor types including lung cancer that"
X Link 2025-11-09T18:05Z [----] followers, [----] engagements

"$IBRX ultraBullish case @alc2022 $IBRX ANKTIVA dominates lymphopenia reset Reverses low lymphocytes rescues checkpoints in 70%+ cancers Long COVID cure-all Phase [--] data [----] = $100B+ market capture (65M+ patients globally) Spike protein cancer explosion Post-COVID oncology boom; ANKTIVA as universal Bioshield Pipeline nukes competition NSCLC BLA [----] GBM lymphoma HIV $20B+ peak sales M&A or mega-partner Big Pharma pays $200B+ premium to own IL-15 platform Shares 985M $100B MC = $101/share (50x from $2) Dilution Always there but could be supported by Cash runway + revenue explosion funds"
X Link 2025-11-09T22:32Z [----] followers, [----] engagements

"$IBRX #Bioshield #Anktiva I am so happy for GretchMick She updates her [--] months post Bioshield status and so far so good @LoriMills4CA42 @drpatrick @DrMakaryFDA @ScottAdamsSays @SecKennedy @alc2022 [--] months Post BioShield Update πŸ‘ŠπŸΌ#Bioshield #cancer #coloncancer #lymphopenia #ALC @drpatrick $IBRX https://t.co/6Se7ei1pqb [--] months Post BioShield Update πŸ‘ŠπŸΌ#Bioshield #cancer #coloncancer #lymphopenia #ALC @drpatrick $IBRX https://t.co/6Se7ei1pqb"
X Link 2025-11-10T20:39Z [----] followers, [----] engagements

"🚨 BREAKING THE CANCER MATRIX 🚨 Yo @elonmusk @JoeRogan bring @drpatrick on the pod RIGHT NOW Were DONE with chemo & radiation that fail 90%+ of patients and destroy lives. BioShield is the paradigm-shifting nuclear option weve all been waiting for an actual immune BIOSHIELD thats saving people BIG TIME. Whos ready to end cancer in our lifetime πŸ”₯πŸ”₯πŸ”₯ Tag everyone. Retweet if you want this convo to go VIRAL. $IBRX #ANKTIVARevolution #BioShieldRevolution #CancerKiller #EndChemoEra"
X Link 2025-11-11T00:42Z [----] followers, [----] engagements

"$IBRX πŸ’” ANKTIVA vs CHEMO/RAD πŸ’” #Bladdercancer #pancreascancer #LungCancer #ProstateCancer Chemo: POISONS your body. KILLS your immune army (500). Leaves families broken. ANKTIVA: IGNITES 10000+ WARRIORS inside you. Spares your hair your strength your HOPE. 70% CURE when all else failed. One steals life. One GIVES IT BACK. STOP THE SUFFERING. CHOOSE ANKTIVA. #oncologists #Hospitals #urologists #Pharmacists #AnktivaForTheFighters #NoMoreTears @ImmunityBio #Bioshield"
X Link 2025-11-12T07:46Z [----] followers, [----] engagements

"$IBRX #Bioshield #ANKTIVA @drpatrick Just wrapped a πŸ”₯ riveting session with oncologists & results of patientsirrefutable proof ANKTIVA supercharges NK/T cells to ERADICATE cancer πŸ’₯ One-hour special w/ doctors & miracle outcomes airing SOON πŸ“Ίβœ¨ We the public Eagerly awaiting FDA green-light for ALL indications πŸš€ Hope is SOARING 🌟With urgency & optimism πŸ™Œ @DrMakaryFDA @VPrasadMDMPH @NIHDirector_Jay Just completed a long discussion about the results of patients receiving Anktiva to expand their NK cells and T cells. It is irrefutable that NK and T cells are key immune cells that kill"
X Link 2025-11-15T16:21Z [----] followers, [----] engagements

"$IBRX This is our mission: secure FDA approval for ANKTIVA across all indicationsno delays no denials no bureaucratic mercy. Jeff Rose a proud American battling stage [--] prostate cancer deserves to walk into his doctors office and receive this life-saving therapy today. @DrMakaryFDA @FDAAre you listening APPROVE ANKTIVA NOW. @JeffRoseTV πŸ’ͺ @drpatrick Thank you for all youre doing Dr. Soon-Shiong. I have been praying for my friend @LoriMills4CA42 and her husband. Im so grateful you are able to help them. I too am hoping you can help me. I am stage [--] metastatic prostate cancer. Ive been on"
X Link 2025-11-15T18:04Z [----] followers, [----] engagements

"$IBRX Did you realize your very life depends on your immune systemthe one thats quietly crumbling from age junk food couch-potato days and every ailment youve battled Even if youre already doing everything right ANKTIVA can explode your immunity 300%+ locking in youthful energy unbreakable vitality and the power to outrun time itself. The FDA has already proven ANKTIVAs safety and efficacy in BCG-unresponsive bladder cancerpatients who were out of options are now cancer-free and thriving. Thats not hype; thats Level [--] evidence. With a mechanism that supercharges NK cells and T-cells across"
X Link 2025-11-15T20:59Z [----] followers, [----] engagements

"$IBRX @drpatrick @US_FDA are you listening Here is a proud American mother plea to the FDA: FDA: IM BEGGING AS A MOTHER. My sonStage [--] colon cancer. Standard of care Exhausted. Hes perfect for the Anktiva lymphopenia trialexcept ONE count [--] points too high Hes a fit devoted young dadtucking in his babies dreaming of their graduations. Cancers trying to steal him. Compassionate use. PLEASE Anktivas saving lives across cancersdont let a number orphan my grandchildren. He deserves to fight. To live. To hold them. FDASAVE MY BOY #RightToTry @FDA πŸ˜­πŸ™ @DrMakaryFDA @VPrasadMDMPH @SecKennedy"
X Link 2025-11-16T03:59Z [----] followers, 13.5K engagements

"$IBRX ANKTIVA Julie glad to hear Bioshield is working for you. Congrats Please keep us up to date. Thank you i suddenly realized just now: one of my major symptoms for over a year has been constant pressure around & behind my left eye. i dont feel it at all right now major victory for Anktiva. i dont know what causes it (i think maybe cryoglobulins caused by covid) but Anktiva got it i suddenly realized just now: one of my major symptoms for over a year has been constant pressure around & behind my left eye. i dont feel it at all right now major victory for Anktiva. i dont know what causes it"
X Link 2025-11-16T06:21Z [----] followers, [----] engagements

"Sir these 10000+ pages arent just paper theyre parents praying for one more birthday children begging for their moms laugh spouses clinging to empty beds at night. Every sheet is a soul screaming for hope. Your clinic answering each one Thats humanity at its rawest most beautiful. A Cancer Hotline + podcast YES. A thousand times YES. Let survivors voices crack through the airwaveslet ANKTIVAs 10-year miracles shatter the silence. Give families something to hold onto when scans steal their breath. Im crying and voting YES. Who else feels this in their bones πŸ™πŸ’” #ANKTIVA #CancerHotline"
X Link 2025-11-17T02:05Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@bullishbruk
/creator/twitter::bullishbruk